<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Gynae Oncology - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  background: url("assets/background.jpg") center center / cover no-repeat fixed;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
}

body::before {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* Responsive utilities */
@media (max-width: 768px) {
  .glass-card {
    border-radius: 16px;
  }
  
  .glass {
    border-radius: 12px;
  }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Obstetrics & Gynecology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">99</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="flex container mx-auto px-6 gap-8">
        <!-- Question Navigation Sidebar -->
        <div class="w-80 glass p-6 h-fit sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="flex-1 max-w-4xl">
            <div class="glass-card p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <!-- Explanation Video -->
                    <div id="solutionVideo" class="hidden">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

    <script>
        let questionsData = [
  {
    "id": 19344,
    "choices": [
      {
        "id": 77336,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">The squamocolumnar junction everts outside with age under the influence of estrogen.</span></span></p>"
      },
      {
        "id": 77337,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Endocervix is lined with squamous epithelium and ectocervix is lined with columnar epithelium.</span></span></p>"
      },
      {
        "id": 77338,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Endocervix undergoes Squamous metaplasia.</span></span></p>"
      },
      {
        "id": 77339,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Metaplastic cells in this transformation zone are prone to develop Cervical cancer.</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following statements regarding squamocolumnar junction is false?</span></span></span></p>",
    "unique_key": "Q1257871",
    "question_audio": null,
    "question_video": null,
    "map_id": 19317,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Endocervix is lined with squamous epithelium and ectocervix is lined with columnar epithelium.</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Squamocolumnar junction is the transition zone between the endocervix and ectocervix.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endocervix is lined with columnar epithelium which gets abruptly transformed into Ectocervix which is lined with squamous epithelium. This is known as Squamous metaplasia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">With age, under the influence of estrogen, the endocervix everts out and the transformation zone keeps coming outwards the internal os. This zone is prone to HPV infection resulting in development of carcinoma cervix.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901127.jpg\" style=\"height:382px; width:500px\" /></span></span></span></p>",
    "correct_choice_id": 77337,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 19345,
    "choices": [
      {
        "id": 77340,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Breast cancer</span></span></p>"
      },
      {
        "id": 77341,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Cervical cancer </span></span></p>"
      },
      {
        "id": 77342,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Endometrial cancer</span></span></p>"
      },
      {
        "id": 77343,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Ovarian cancer</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most preventable gynecological cancer is: </span></span></p>",
    "unique_key": "Q6234018",
    "question_audio": null,
    "question_video": null,
    "map_id": 19318,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. Cervical cancer</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: FIGO cancer report 2021</span></strong></span></span></p>",
    "correct_choice_id": 77341,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19224,
    "choices": [
      {
        "id": 76856,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Breast cancer</span></span></span></p>"
      },
      {
        "id": 76857,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Cervical cancer </span></span></span></p>"
      },
      {
        "id": 76858,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Endometrial cancer</span></span></span></p>"
      },
      {
        "id": 76859,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Ovarian cancer</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The most preventable gynaecological cancer is : </span></span></span></p>",
    "unique_key": "Q2825333",
    "question_audio": null,
    "question_video": null,
    "map_id": 19279,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B. Cervical cancer</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: FIGO cancer report 2021</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cervical cancer should be considered the most preventable cancer in our lifetime.</span></span></span></span></p>",
    "correct_choice_id": 76857,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19226,
    "choices": [
      {
        "id": 76864,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"color:black\">70% of girls fully vaccinated by the age of 15&nbsp;years</span></span></span></span></p>"
      },
      {
        "id": 76865,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"color:black\">70% of women screened by the age of 35&nbsp;years and again by 45&nbsp;years</span></span></span></span></p>"
      },
      {
        "id": 76866,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"color:black\">90% of girls fully vaccinated by the age of 15&nbsp;years</span></span></span></span></p>"
      },
      {
        "id": 76867,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"color:black\">90% of women with precancer/ cancer treated and managed appropriately</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following is NOT true in &ldquo;WHO global strategy for eliminating cervical cancer&rdquo; by 2030. </span></span></span></span></p>",
    "unique_key": "Q1930075",
    "question_audio": null,
    "question_video": null,
    "map_id": 19280,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A. </span></span></strong><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">70% of girls fully vaccinated by the age of 15&nbsp;years</span></span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Global strategy to accelerate the elimination of cervical cancer as a public health problem available at </span></span><a href=\"https://www.who.int/publications/i/item/9789240014107\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">https://www.who.int/publications/i/item/9789240014107</span></span></strong></a></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">As per WHO global strategy for eliminating cervical cancer,</span></span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> the following 90-70-90 targets that must be met by 2030 for countries to be on the path towards cervical cancer elimination:</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">90% of girls fully vaccinated with HPV vaccine by age 15 years.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">70% of women are screened with a high-performance test by 35 years of age and again by 45 years of age</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">90% of women identified with cervical disease receive treatment (90% of women with precancer treated, and 90% of women with invasive cancer managed).</span></span></span></span></p>",
    "correct_choice_id": 76864,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19228,
    "choices": [
      {
        "id": 76872,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"color:black\">Cervarix</span></span></span></p>"
      },
      {
        "id": 76873,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"color:black\">Cervavac</span></span></span></p>"
      },
      {
        "id": 76874,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"color:black\">Gardasil</span></span></span></p>"
      },
      {
        "id": 76875,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"color:black\">Gardasil 9</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A P4L4, 43-year-old woman presents to OPD with post coital bleeding. On cervical biopsy, she is found to have CIN III. You counsel her about her treatment and also guide her for preventive strategy for her 2 daughters (17 years, 12-year-old) with HPV vaccine.&nbsp;</span></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following is the indigenous cervical cancer vaccine soon to be available in India by serum institute of India: </span></span></span></span></p>",
    "unique_key": "Q9820651",
    "question_audio": null,
    "question_video": null,
    "map_id": 19281,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B. Cervavac</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: </span></span></strong><a href=\"https://isccp.in/cervavac-the-new-buzz/\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">https://isccp.in/cervavac-the-new-buzz/</span></span></strong></a></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The National Cancer Institute of the US National Institute of Health (NIH) reports that three vaccines are currently being offered in numerous nations all over the world to prevent infection with the disease-causing HPV. These include Cervarix, Gardasil, and Gardasil 9.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The vaccines Cervarix is bivalent, Gardasil 9 is nonavalent, and Gardasil is quadrivalent. This translates to four, nine, and two HPV strains in Gardasil, Gardasil 9, and Cervarix, respectively.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPV types 6, 11, 16, and 18 are prevented by Gardasil, while HPV types 16 and 18 are prevented by Cervarix.<br />\r\nInfection with HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58 is prevented with Gardasil 9.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cervavac: Tetravalent or quadrivalent L1 virus-like particles (VLPs) of serotypes 6, 11, 16, and 18 are part of the serum institute of India (SII)&rsquo;s HPV vaccination.&nbsp;</span></span></span></span></span></p>",
    "correct_choice_id": 76873,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 19230,
    "choices": [
      {
        "id": 76880,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Ayers spatula for Pap smear </span></span></span></p>"
      },
      {
        "id": 76881,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Cytobrush for Liquid based cytology </span></span></span></p>"
      },
      {
        "id": 76882,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Pipelle&rsquo;s for endometrial aspiration</span></span></span></p>"
      },
      {
        "id": 76883,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Vaginal swab for chlamydia screening </span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Identify the procedure done with the instrument given: </span></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-190188_nDAGw7I.jpg\" style=\"height:302px; width:400px\" /></p>",
    "unique_key": "Q2420326",
    "question_audio": null,
    "question_video": null,
    "map_id": 19282,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: B: Cytobrush for Liquid based cytology</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Berek and novak 16<sup>th</sup> edition, page number 925</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The ubiquitous use of liquid-based medium to collect the cytologic sample and preserve the collected cervical cells significantly decreased specimen sampling and preparation errors.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">With this technique, liquid samples areprocessed to provide a uniform, thin layer of cervical cells without debris on a glass slide. The cell sample is collected with an endocervical brush used in combination with a plastic spatula or with a plastic broom. The sample is rinsed in a vial containing liquid alcohol-based preservative. With this technique, 80% to 90% of the cells are transferred to the liquid media, as compared with the 10% to&nbsp;</span></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">20% transferred to the glass slide with conventional cytologic testing. Use of liquid-based media eliminates air drying. The cells are retrieved from the vial by passing the liquid through a filter, which traps the larger epithelial cells, separating them from the small blood and inflammatory cells. This process yields a thin layer of diagnostic cells properly preserved and more easily interpreted by the cytologist. This technique reduces by 70% to 90% the rate of unsatisfactory samples encountered with conventional cytologic testing</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: DC dutta textbook of gynaecology page no: 627</span></span></strong></span></span></p>",
    "correct_choice_id": 76881,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "InstrumentsBased"
    ]
  },
  {
    "id": 19231,
    "choices": [
      {
        "id": 76884,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Cervical biopsy</span></span></span></p>"
      },
      {
        "id": 76885,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Endometrial aspiration</span></span></span></p>"
      },
      {
        "id": 76886,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">HPV testing </span></span></span></p>"
      },
      {
        "id": 76887,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Pap&rsquo;s smear</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Identify the procedure being done in the image given below?</span></span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/2_NDv9EG0.jpg\" style=\"height:509px; width:1046px\" /></span></span></span></p>",
    "unique_key": "Q1151811",
    "question_audio": null,
    "question_video": null,
    "map_id": 19283,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D. Pap&rsquo;s smear</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref DC DUTTA 6<sup>th</sup> edition, page 110. </span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">(PYQ) the material from the cervix is best collected <strong>using Ayre&rsquo;s spatula</strong> made of wood or plastic. Whole of the squamocolumnar junction has to be scrapped to obtain good material </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">(PYQ) The material so collected should be immediately spread over a microscopic slide and at once put into the fixative ethyl alcohol (95%) before drying. After fixing for about 30 minutes, the slide is taken out, air dried and sent to the laboratory with proper identification. The slide so sent is stained either with Papanicolaou&rsquo;s or Sorr&rsquo;s method and examined by a trained cytologist. </span></span></span></span></p>",
    "correct_choice_id": 76887,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 19234,
    "choices": [
      {
        "id": 76896,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Colposcopy </span></span></span></p>"
      },
      {
        "id": 76897,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">High vaginal swab</span></span></span></p>"
      },
      {
        "id": 76898,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Liquid based Cytology</span></span></span></p>"
      },
      {
        "id": 76899,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Pap&rsquo;s smear</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Mrs X, 45-year-old female comes for cervical cancer screening. Identify the procedure being done in the image:</span></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-190189.jpg\" style=\"height:428px; width:900px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>",
    "unique_key": "Q2610461",
    "question_audio": null,
    "question_video": null,
    "map_id": 19284,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: C: liquid based Cytology</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Berek and novak 16<sup>th</sup> edition, page number 925</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The ubiquitous use of liquid-based medium to collect the cytologic sample and preserve the collected cervical cells significantly decreased specimen sampling and preparation errors.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">With this technique, liquid samples are processed to provide a uniform, thin layer of cervical cells without debris on a glass slide. The cell sample is collected with an endocervical brush used in combination with a plastic spatula or with a plastic broom. The sample is rinsed in a vial containing liquid alcohol-based preservative. With this technique, 80% to 90% of the cells are transferred to the liquid media, as compared with the 10% to</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">20% transferred to the glass slide with conventional cytologic testing. Use of liquid-based media eliminates air drying.</span></span></span></span></p>",
    "correct_choice_id": 76898,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 19237,
    "choices": [
      {
        "id": 76908,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Colposcopy</span></span></span></p>"
      },
      {
        "id": 76909,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">HPV testing</span></span></span></p>"
      },
      {
        "id": 76910,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Liquid based Cytology</span></span></span></p>"
      },
      {
        "id": 76911,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Pap&rsquo;s smear</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 38-year-old female, P3L3 comes to Gynaecology OPD for routine checkup, and you offer her cervical cancer screening. Which is the preferred primary modality for cervical cancer screening</span></span></span></p>",
    "unique_key": "Q5459328",
    "question_audio": null,
    "question_video": null,
    "map_id": 19285,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: B : HPV testing </span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Recent update in WHO,2021</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition, 2021</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO recommends using HPV DNA detection as the primary screening test rather than VIA or cytology in screening and treatment approaches among both the general population of women and women living with HIV. </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Existing programmes with quality-assured cytology as the primary screening test should be continued until HPV DNA testing is operational; existing programmes using VIA as the primary screening should transition rapidly because of the inherent challenges with quality assurance. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Methods for cervical cancer screening: </span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/5_0BGImRb.jpg\" style=\"height:389px; width:1197px\" /></span></span></strong></span></span></p>",
    "correct_choice_id": 76909,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 19239,
    "choices": [
      {
        "id": 76916,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">HPV testing should be used as a method of cancer cervix screening after 25 years of age </span></span></span></p>"
      },
      {
        "id": 76917,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">HPV should only be used in adjunct with either Pap&rsquo;s smear or liquid based cytology</span></span></span></p>"
      },
      {
        "id": 76918,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">An interval of 5-10 years is recommended when using HPV as primary screening </span></span></span></p>"
      },
      {
        "id": 76919,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Women with previous 2 HPV screen negative can stop screening after the age of 60 years</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Human Papilloma Virus (HPV) is the causative agent in majority of cervical cancers. Which of the following is TRUE in relation to HPV testing as per WHO guidelines?</span></span></span></p>",
    "unique_key": "Q7407835",
    "question_audio": null,
    "question_video": null,
    "map_id": 19286,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: C: Interval of 5-10 years is recommended when using HPV as primary screening </span></span></strong></span></span></p>\r\n\r\n<p><strong>Explanation:&nbsp;</strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO recommends starting regular cervical cancer screening at the <strong>age of 30 years </strong>among the general population of women.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO recommends using <strong>HPV DNA detection as the primary screening test </strong>rather than VIA or cytology in screening and treatment approaches among both the general population of women and women living with HIV</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO suggests a <strong>regular screening interval of every 5 to 10 years when using HPV DNA </strong>detection as the primary screening test among the general population of women</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">After the age of 50 years</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other options:&nbsp;</span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Option A: HPV testing should be used as a method of cancer cervix screening after 25 years of age: This is incorrect as screening with HPV should start at age 30&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Option B:&nbsp;HPV should only be used in adjunct with either Pap&rsquo;s smear or liquid based cytology: This is also incorrect. As per WHO, HPV alone is the preferred screening test</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Option D:&nbsp;Women with previous 2 HPV screen negative can stop screening after the age of 60 years: This is also incorrect.&nbsp;</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">After the age of 50 years</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:&nbsp;</span></span></span></span></strong></em></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO recommends starting regular cervical cancer screening at the <strong>age of 30 years </strong>among the general population of women.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO recommends using <strong>HPV DNA detection as the primary screening test </strong>rather than VIA or cytology in screening and treatment approaches among both the general population of women and women living with HIV</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO suggests a <strong>regular screening interval of every 5 to 10 years when using HPV DNA </strong>detection as the primary screening test among the general population of women</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">After the age of 50 years</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition, 2021</span></span></strong></span></span></p>",
    "correct_choice_id": 76918,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased"
    ]
  },
  {
    "id": 19244,
    "choices": [
      {
        "id": 76936,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Cervical biopsy</span></span></span></p>"
      },
      {
        "id": 76937,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Liquid based cytology</span></span></span></p>"
      },
      {
        "id": 76938,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Visual inspection with acetic acid</span></span></span></p>"
      },
      {
        "id": 76939,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Visual inspection with lugol&rsquo;s iodine</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A woman visited hospital in rural area for &ldquo;see and treat&rdquo; cervical cancer screening. Which method is being used for screening in the given image:</span></span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/1_akrJ1Ac.jpg\" style=\"height:254px; width:338px\" /></span></span></span></p>",
    "unique_key": "Q7985815",
    "question_audio": null,
    "question_video": null,
    "map_id": 19287,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">And C: Visual inspection with acetic acid</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Visual inspection with acetic acid (VIA): </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A speculum is introduced and acetic acid is applied to the cervix. Those women with acetowhite lesions are considered abnormal. </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Done with 3% acetic acid.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: DC dutta textbook of gynaecology 6<sup>th</sup> edition, page 324, fig: 22.6A</span></span></strong></span></span></p>",
    "correct_choice_id": 76938,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 19245,
    "choices": [
      {
        "id": 76940,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Cervical biopsy</span></span></span></p>"
      },
      {
        "id": 76941,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Liquid based cytology</span></span></span></p>"
      },
      {
        "id": 76942,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Visual inspection with acetic acid</span></span></span></p>"
      },
      {
        "id": 76943,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Visual inspection with lugol&rsquo;s iodine</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Identify the procedure done in the above image: </span></span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/1_R4PwilP.jpg\" style=\"height:433px; width:578px\" /></span></span></span></p>",
    "unique_key": "Q6829137",
    "question_audio": null,
    "question_video": null,
    "map_id": 19288,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: D. Visual inspection with lugol&rsquo;s iodine</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Employing iodine solution (Schiller&rsquo;s 0.3% or Lugol&rsquo;s 5%), multiple punch biopsies are taken from the <strong>unstained areas</strong>. Stained areas (normal) appear brown due to presence of glycogen </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: dc dutta gynaecology, 6<sup>th</sup> edition.&nbsp; page 325. </span></span></strong></span></span></p>",
    "correct_choice_id": 76943,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 19246,
    "choices": [
      {
        "id": 76944,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Colposcopy</span></span></span></p>"
      },
      {
        "id": 76945,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Hysteroscopy</span></span></span></p>"
      },
      {
        "id": 76946,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Laparoscopy</span></span></span></p>"
      },
      {
        "id": 76947,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Vaginoscopy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 35-year-old woman underwent Pap smear screening which showed HSIL/ CIN III. The woman was advised further the following test. Identify the procedure: </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/3_vUJG0SF.jpg\" style=\"height:227px; width:418px\" /></span></span></span></p>",
    "unique_key": "Q7604785",
    "question_audio": null,
    "question_video": null,
    "map_id": 19289,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: A. Colposcopy</span></span></strong></span></span></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref DC DUTTA 6<sup>th</sup> edition, page 116, fig: 9.20</span></span></span></strong></p>",
    "correct_choice_id": 76944,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 19018,
    "choices": [
      {
        "id": 76032,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Clear cell </span></span></p>"
      },
      {
        "id": 76033,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Mucinous</span></span></p>"
      },
      {
        "id": 76034,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Serous</span></span></p>"
      },
      {
        "id": 76035,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Transitional </span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common type of epithelial ovarian tumors are: </span></span></p>",
    "unique_key": "Q1503125",
    "question_audio": null,
    "question_video": null,
    "map_id": 31030,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: C. Serous</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">75-80% of epithelial cancers are serous histologic type</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Classification of ovarian tumors:&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image_v42aRtk.png\" style=\"height:311px; width:410px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">The commonest type of ovarian cancer is epithelial ovarian cancer, amongst which, serous type is most common</span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak 16 ed, page 2547</strong></span></span></p>",
    "correct_choice_id": 76034,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 19027,
    "choices": [
      {
        "id": 76068,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bilateral mastectomy </span></span></p>"
      },
      {
        "id": 76069,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bilateral salpingo oophorectomy</span></span></p>"
      },
      {
        "id": 76070,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">HPV vaccine</span></span></p>"
      },
      {
        "id": 76071,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oral contraceptive pill</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old unmarried girl, whose mother died of ovarian cancer comes to you for advice regarding prevention of ovarian cancer. Which of the following will you suggest her for prevention of ovarian cancer: </span></span></p>",
    "unique_key": "Q2334045",
    "question_audio": null,
    "question_video": null,
    "map_id": 31031,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: D. Oral contraceptive pill</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\">OCP is the only documented method of chemoprevention for prevention of ovarian cancer. </span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><strong><span style=\"font-family:Calibri,sans-serif\">Other Options:&nbsp;</span></strong></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A and B:</strong> Salpingooophorectomy and mastectomy are&nbsp;advisable after genetic testing in women with strong family history of ovariana and breast cancer. Also as she is unmarried, doing a salpingectomy now would not be a suitable surgery as she might want to concieve in the future.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong> HPV vaccine prevents cervical cancer. </span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Risk Factors for epithelial ovarian cancer</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Nulliparity</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Early menarche, late menopause</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>White race</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Increasing age</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Family history</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Personal h/o breast cancer</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Ethnicity (European jews, Icelandic and Hungarian)</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Post menopausal HRT</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>PID</strong></em></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:16px\">Protective Factors for Ovarian cancer</span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><em><strong><span style=\"font-size:16px\">B/l salpingectomy or tubal ligation</span></strong></em></li>\r\n\t<li><span style=\"font-size:16px\"><strong><em>Oophorectomy</em></strong></span></li>\r\n\t<li><span style=\"font-size:16px\"><strong><em>Combined OCP</em></strong></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Pregnancy and breast feeding</strong></em></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: berek and noval 16 edition, page 2561</strong></span></span></p>",
    "correct_choice_id": 76071,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 19029,
    "choices": [
      {
        "id": 76076,
        "text": "<p><span style=\"font-size:12pt;\">Both BRCA1 and BRCA2 are associated with increased risk of ovarian cancer</span></p>"
      },
      {
        "id": 76077,
        "text": "<p><span style=\"font-size:12pt;\">Hereditary cancer tends to occur in women 10 years earlier than the non-hereditary ovarian cancers</span></p>"
      },
      {
        "id": 76078,
        "text": "<p><span style=\"font-size:12pt;\">Most BRCA related ovarian cancers are high grade mucinous cancers</span></p>"
      },
      {
        "id": 76079,
        "text": "<p><span style=\"font-size:12pt;\">Prophylactic salpingo oophorectomy reduces risk of BRCA related gynecological cancer by 95%</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is FALSE regarding BRCA related hereditary ovarian cancer?</span></p>",
    "unique_key": "Q5605405",
    "question_audio": null,
    "question_video": null,
    "map_id": 31032,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Most BRCA related ovarian cancers are high grade mucinous cancers</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Most BRCA related ovarian cancers are high grade serous cancers</span></li><li><span style=\"font-size:16px;\">Offer risk reducing bilateral salpingooophoerctomy to patients with BRCA 1 mutation at 35-40 years and BRCA 2 mutation by 40-45 years</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A:&nbsp;</strong>Both BRCA1 and BRCA2 are associated with increased risk of ovarian cancer</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">The BRCA1 gene is located on chromosome 17q21.&nbsp;Patients with a proven mutation have a dramatically elevated risk of developing ovarian cancer (About 40%).</span></li><li><span style=\"font-size:16px;\">BRCA2 is located on chromosome 13q12 and in general is less likely to lead to ovarian cancer (12 to 20%).</span></li><li><span style=\"font-size:16px;\">The&nbsp;estimated lifetime risk of breast cancer with a BRCA1 or BRCA2 mutation is 65 -&nbsp;74 percent</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B:&nbsp;</strong>Hereditary cancer tends to occur in women 10 years earlier than the non-hereditary ovarian cancers. This is a correct statement</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D:</strong>&nbsp;Prophylactic salpingo oophorectomy reduces risk of BRCA related gynecological cancer by 95% and should be done once a woman who is BRCA positive, her family is complete.&nbsp;The only proven way to directly prevent ovarian cancer is surgical removal. In BRCA1 or BRCA2 carriers, prophylactic bilateral salpingo-oophorectomy (BSO) may be performed either upon completion of childbearing or by age 40 years</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>BRCA-Related Ovarian Cancer&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>BRCA genes (BRCA1 &amp; BRCA2)</strong> are tumor suppressor genes involved in <strong>DNA repair via homologous recombination</strong>.</span></li><li><span style=\"font-size:16px;\"><strong>Germline mutations</strong> in BRCA1 or BRCA2 increase the risk of <strong>high-grade serous epithelial ovarian cancer</strong> (HGSOC).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Diagnosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">All patients with epithelial ovarian cancer are advised to undergo <strong>genetic testing for BRCA mutations</strong>, regardless of age or family history.</span></li><li><span style=\"font-size:16px;\">Testing includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Germline BRCA1/2</span></li><li><span style=\"font-size:16px;\">Somatic BRCA testing (from tumor tissue)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Prognosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">BRCA-associated cancers have <strong>better initial response to platinum-based chemotherapy</strong>.</span></li><li><span style=\"font-size:16px;\">Improved <strong>progression-free survival</strong> and overall survival, especially with BRCA2.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Targeted Therapy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>PARP inhibitors</strong> (e.g., olaparib, niraparib):</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Exploit synthetic lethality in BRCA-deficient cells</span></li><li><span style=\"font-size:16px;\">Used as <strong>maintenance therapy</strong> post-chemotherapy or in recurrent disease</span></li><li><span style=\"font-size:16px;\">Most effective in <strong>BRCA-mutated and homologous recombination deficient (HRD)</strong> tumors</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Prevention</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Risk-reducing salpingo-oophorectomy</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Recommended at 35\u201340 years (BRCA1) or 40\u201345 years (BRCA2)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">The BRCA genes increase the risk of serous epithelial ovarian cancers and breast cancers</span></li><li><span style=\"font-size:16px;\">BRCA1 gene is located on chromosome 17q21.&nbsp;Patients with a proven mutation have a dramatically elevated risk of developing ovarian cancer (About 40%).</span></li><li><span style=\"font-size:16px;\">BRCA2 is located on chromosome 13q12 and in general is less likely to lead to ovarian cancer (12 to 20%).</span></li><li><span style=\"font-size:16px;\">The&nbsp;estimated lifetime risk of breast cancer with a BRCA1 or BRCA2 mutation is 65 -&nbsp;74 percent</span></li><li><span style=\"font-size:16px;\">The only proven way to directly prevent ovarian cancer is surgical removal.</span></li><li><span style=\"font-size:16px;\">In BRCA1 or BRCA2 carriers, prophylactic bilateral salpingo-oophorectomy (BSO) may be performed either upon completion of childbearing or by age 40 years</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Berek and Novak 16 edition, pg 2566, Page 738, Williams Gynecology 3rd edition</strong></span></p>",
    "correct_choice_id": 76078,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 19030,
    "choices": [
      {
        "id": 76080,
        "text": "<p><span style=\"font-size:12pt;\">Stage of the disease is I C3</span></p>"
      },
      {
        "id": 76081,
        "text": "<p><span style=\"font-size:12pt;\">The surgery is staging laparotomy with bilateral salpingectomy with omentectomy with pelvic and paraaortic lymphadenectomy</span></p>"
      },
      {
        "id": 76082,
        "text": "<p><span style=\"font-size:12pt;\">Post operative chemotherapy will be required</span></p>"
      },
      {
        "id": 76083,
        "text": "<p><span style=\"font-size:12pt;\">5-year Survival is around 70%</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 50-year-old postmenopausal woman underwent staging laparotomy for ovarian malignancy. Intraoperatively, there was ascites present, 10*10 cm right ovarian cyst with an intact capsule, which ruptured during surgery to reveal solid areas, omentum had a 3*3cm deposit. The rest of abdominal organs were normal on palpation. On histopathology, ascites showed malignant cells, ovaries had serous carcinoma and the omentum showed malignant cells. Lymph nodes were free of tumor cells. Which of the following is TRUE for the patient?</span></p>",
    "unique_key": "Q4781988",
    "question_audio": null,
    "question_video": null,
    "map_id": 31033,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Post operative chemotherapy will be required</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">As per the FIGO staging for ovarian carcinoma (which is a surgical staging), she has stage IIIc disease. </span><span style=\"background-color:transparent;font-size:12pt;\">as she has an abdominal deposit (omental deposit) of 3 cm</span></li><li><span style=\"font-size:12pt;\">lymph nodes are negative, there is no evidence of organ metastasis.</span></li><li><span style=\"font-size:12pt;\">The FIGO staging is shown below</span></li><li><span style=\"font-size:12pt;\">The primary mode of treatment of ovarian cancer is SURGICAL STAGING (which involves removing the uterus and ovaries with debulking of tumor tissue) followed by CHEMOTHERAPY (Platinum based - Cisplatin or Carboplatin&nbsp; + Paclitaxel)</span></li></ul><p>&nbsp;</p><p><strong>FIGO Staging of ovarian cancer</strong></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/ovarian-cancer-staging-figo.jpg\" alt=\"\" width=\"1000\" height=\"1103\"></p><p>&nbsp;</p><p><strong>Other Options:&nbsp;</strong></p><p>&nbsp;</p><p><strong>Option A:&nbsp;</strong><span style=\"font-size:12pt;\">Stage of the disease is I C3: The Stage is stage 3&nbsp;</span></p><p>&nbsp;</p><p><strong>Option B:</strong>&nbsp;<span style=\"font-size:12pt;\">The surgery for ovarian cancer is staging laparotomy with bilateral salpingectomy with omentectomy with pelvic and paraaortic lymphadenectomy: The surgery is staging laprotomy which includes Total abdominal hysterectomy with b/l salpingo-oophorectomy with pelvic and para-aortic LN dissection with omentectomy with optimal debulking of visible tumor tissue</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: </strong>5 year survival is 70%:&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">In ovarian&nbsp;cancer, 5-year survuval in Stage 1 is 90%, stage 2 is 70%, stage 3 is 40% and stage 4 is 20%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The primary mode of treatment of ovarian cancer is SURGICAL STAGING (which involves removing the uterus and</span></li><li><span style=\"font-size:12pt;\">ovaries with debulking of tumor tissue) followed by CHEMOTHERAPY (Platinum based - Cisplatin or Carboplatin&nbsp; + Paclitaxel)</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Berek and novak 16 edition, 2577&nbsp;(page 2619)&nbsp;</strong></span></p>",
    "correct_choice_id": 76082,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 19031,
    "choices": [
      {
        "id": 76084,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bleomycin etopocide cisplatin (BEP)</span></span></p>"
      },
      {
        "id": 76085,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Carboplatin paclitaxel (CP)</span></span></p>"
      },
      {
        "id": 76086,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">EMACO</span></span></p>"
      },
      {
        "id": 76087,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Methotrexate</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old female has epithelial ovarian tumor which on evaluation has been found to be unresectable and planned for neoadjuvant chemotherapy. Which of the following is the most suitable drug/drug combination for her?</span></span></p>",
    "unique_key": "Q7193836",
    "question_audio": null,
    "question_video": null,
    "map_id": 31034,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. Carboplatin paclitaxel (CP)</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\">Neoadjuvant chemotherapy is an option for patients with advanced ovarian cancer who have a low likelihood of optimal cytoreduction/high perioperative risk. </span></span></li>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\">Carboplatin paclitaxel is the most commonly used chemotherapy for epithelial ovarian cancer. </span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><em><strong><span style=\"font-size:14px\">Other Options:</span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Option A:</strong> BEP protocol (Bleomycin, Etoposide, Paclitaxel) is the chemotherapy of choice in germ cell tumors</span></li>\r\n\t<li><strong>Option C:</strong> EMACO is the chemotherapy given in high risk choriocarcinoma</li>\r\n\t<li><strong>Option D:</strong> Methotrexate is recommended in low risk choriocarcinoma</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\">Neoadjuvant chemotherapy is an option for patients with advanced ovarian cancer who have a low likelihood of optimal cytoreduction/high perioperative risk. </span></span></li>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\">Carboplatin paclitaxel is the most commonly used chemotherapy for epithelial ovarian cancer.</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek and novak 16 edition, 2600-02</strong></span></span></p>",
    "correct_choice_id": 76085,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 19037,
    "choices": [
      {
        "id": 76108,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">She has clear cell epithelial ovarian tumor</span></span></p>"
      },
      {
        "id": 76109,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">LDH is likely to be increased</span></span></p>"
      },
      {
        "id": 76110,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">She will require completion surgery with total abdominal hysterectomy and salpingooophorectomy </span></span></p>"
      },
      {
        "id": 76111,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">These tumors are chemoresistant </span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old girl presents with adnexal mass and undergoes unilateral salpingooophorectomy. Histopathology shows large clear cells with abundant cytoplasm, large nuclei with fibrous septae containing lymphocytic infiltrate as shown. Which of the following statements is TRUE?</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-753.jpg\" style=\"height:319px; width:400px\" /></span></span></p>",
    "unique_key": "Q6135192",
    "question_audio": null,
    "question_video": null,
    "map_id": 31035,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. LDH is likely to be increased</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">She has dysgerminoma and hence&nbsp;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">LDH which is the tumor marker is likely to be increased</span></span></p>\r\n\r\n<p><em><strong>Other Options:</strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><em><strong>Option A:&nbsp;</strong></em>&nbsp;clear cell epithelial ovarian tumor: Clear cell tumors on microscopy have low cuboidal, polyhedral, <em><strong>hobnail</strong></em> or flattened cells with uniform nuclear atypia, prominent nucleoli and variable mitotic activity</span></span></li>\r\n\t<li><em><strong>Option B:&nbsp;</strong></em><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">She will require completion surgery with total abdominal hysterectomy and salpingooophorectomy:&nbsp;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fertility sparing surgery is preferred. If opposite side is suspicious, biopsy can be taken and chemotherapy is given.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:&nbsp;</strong>These tumors are radioresistant: These tumors are highly radiosensitive and chemosensitive. </span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:</strong></em></span></p>\r\n\r\n<p><em><strong>Dysgerminoma</strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dysgerminoma is the commonest (30&ndash;40%) malignant germ cell tumor.</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">It arises from undifferentiated form of germ cells. </span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">In 5%: Dysgenetic gonads so karyotype may be required</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">The counterpart of dysgerminoma in male is seminoma. </span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Majority (75%) of the tumors occur before the age of 30 years.</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Tumor marker is LDH</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Pathology: The shape is usually round or oval and is usually 5&ndash;15 cm in diameter; It is firm rubbery. It may be bilateral (10%). Cut section shows pink or yellow color. </span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Microscopic appearance: uniform large round cells,&nbsp;&nbsp;arranged in cords or clumps with abundant clear cytoplasm. Nuclei are large, irregular and hyperchromatic with varying degree of mitosis. There is intense infiltration of lymphocytes and plasma cells in the fibrous septum. Malignant in &gt; 50%</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Clinical features:&nbsp;&nbsp;not specific for the tumor. </span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Treatment:</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Majority (75%) of dysgerminomas are confined to one ovary and are stage I at the time of diagnosis&nbsp;In a young patient where preservation of fertility is desired, laparotomy for surgical staging and unilateral salpingo-oophorectomy is done. </span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">If there is any suspicion of involvement to the other ovary, bisection of the contralateral ovary and excisional biopsy should be done. </span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">The tumor is sensitive to both chemotherapy and radiotherapy.&nbsp;</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">BEP (Bleomycin, Etoposide and Cisplatin), VBP (Vinbla-stin, Bleomycin and Cisplatin), VAC (Vincristine, Actinomycin and Cyclophosphamide) are the commonly used drugs for the germ cell tumors.&nbsp;</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak, 16 ed, page 2624-33.</strong></span></span></p>",
    "correct_choice_id": 76109,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "InstrumentsBased"
    ]
  },
  {
    "id": 19038,
    "choices": [
      {
        "id": 76112,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Granulosa cell tumor</span></span></p>"
      },
      {
        "id": 76113,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Yolk sac tumor</span></span></p>"
      },
      {
        "id": 76114,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dysgerminoma</span></span></p>"
      },
      {
        "id": 76115,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dermoid tumor</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Identify the tumor in which this HPE finding is likely?</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-754.jpg\" style=\"height:329px; width:400px\" /></span></span></p>",
    "unique_key": "Q8357959",
    "question_audio": null,
    "question_video": null,
    "map_id": 31036,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. Yolk sac tumor</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is a HPE showing Schiller Duval body with central vessel and mantle of endoderm whish is typically seen in Yolk sac tumor</span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:Calibri,sans-serif\">Other Options:&nbsp;</span></strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option A:</strong></em></span>&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Granulosa cell tumor: Pathognomonic HPE image is Call Exner bodies. Coffee bean nuclei is also seen</span></span></li>\r\n\t<li><em><strong>Option B:</strong>&nbsp;</em><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dysgerminoma: Fried egg appearance is seen in HPE</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><em><strong>Option D:</strong></em> Dermoid: Cell lines of ectoderm, endoderm and mesoderm is seen</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ovarian Tumor Markers:&nbsp;</span></span></strong></em></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak, page 2640 </strong></span></span></p>",
    "correct_choice_id": 76113,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "InstrumentsBased"
    ]
  },
  {
    "id": 19039,
    "choices": [
      {
        "id": 76116,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Schiller duval body</span></span></p>"
      },
      {
        "id": 76117,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Call exner body</span></span></p>"
      },
      {
        "id": 76118,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Psammoma body</span></span></p>"
      },
      {
        "id": 76119,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Leydig cells</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Identify the histopathological finding:</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-755.jpg\" style=\"height:307px; width:400px\" /></span></span></p>",
    "unique_key": "Q4051319",
    "question_audio": null,
    "question_video": null,
    "map_id": 31037,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. Call exner bodies</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Call exner bodies are pathognomonic of granulosa cell tumors</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">They are a</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">rranged in small clusters or rosettes around central cavity, resembling a primordial follicle</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Other Options:&nbsp;</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><strong>Option A: </strong>Schiller Duvall bodies are seen in yolk sac tumors and appear as shown</li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217194937-1.jpeg\" style=\"height:195px; width:259px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option C:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Psammoma body: These are seen in seous epithelial ovarian tumors and appear as shown:&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217195106-2.jpeg\" style=\"height:200px; width:252px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option D: Leydig cells: Reinkes crystals are seen in sertoli leydig cell tumor</strong></li>\r\n</ul>\r\n\r\n<p><img alt=\"reinke's crystals - Leydig cell tumor | Womens health, Health, Tumor\" src=\"https://i.pinimg.com/originals/c9/6d/c6/c96dc66188b5b9a7f415b4a541503e09.png\" /></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak 16 ed, page 2648</strong></span></span></p>",
    "correct_choice_id": 76117,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 19043,
    "choices": [
      {
        "id": 76132,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Granulosa cell tumor</span></span></p>"
      },
      {
        "id": 76133,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Endometriotic cyst</span></span></p>"
      },
      {
        "id": 76134,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dermoid</span></span></p>"
      },
      {
        "id": 76135,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Yolk sac tumor</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the tumor in the image:</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-756.jpg\" style=\"height:400px; width:400px\" /></span></span></p>",
    "unique_key": "Q3711229",
    "question_audio": null,
    "question_video": null,
    "map_id": 31038,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: C. Dermoid </strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>This is the typical gross image of an ovarian dermoid (mature cystic teratoma)</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>It is recognized by the typical hair, teeth and sebacious material</strong></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:&nbsp;</strong>Granulosa cell tumor: The gross appearance is as shown and features include:&nbsp;</span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Well circumscribed, predominantly solid; occasionally solid and cystic</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Lobulated, yellow-tan or tan-white cut surface</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217201516-1.jpeg\" style=\"height:198px; width:254px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option B:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Endometriotic cyst: This typocally has chocolate like material as its content</span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217201807-2.jpeg\" style=\"height:194px; width:259px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option D: </strong>Yolk sac tumor:&nbsp; Appear as&nbsp;<span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">solid gray-white with a gelatinous, myxoid, or mucoid appearance. Necrosis, cystic changes, and hemorrhage are often seen as shown</span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217201941-3.jpeg\" style=\"height:195px; width:259px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong>This is the typical gross pathological image of an ovarian dermoid</strong></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-756.jpg\" style=\"height:400px; width:400px\" /></span></span></p>",
    "correct_choice_id": 76134,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 18984,
    "choices": [
      {
        "id": 75896,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Diabetes</span></span></p>"
      },
      {
        "id": 75897,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Multiparity</span></span></p>"
      },
      {
        "id": 75898,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Obesity</span></span></p>"
      },
      {
        "id": 75899,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Tamoxifen therapy</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 50-year-old woman is diagnosed to have endometrial carcinoma on biopsy. She wishes to understand the high-risk factors for development of endometrial cancer. Which of the following is NOT a risk factor for development of endometrial carcinoma:</span></span></p>",
    "unique_key": "Q9829136",
    "question_audio": null,
    "question_video": null,
    "map_id": 31020,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Multiparity </span></strong></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture1_orutUsD.jpg\" style=\"height:647px; width:850px\" /></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unopposed Estrogen therapy is seen in scenarios like PCOS, estrogen secretinf tumors like granulosa cell tumor and HRT with only estrogen</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:&nbsp;</span></span></strong></em></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk Factors for endometrial cancer include</span></span></strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></span></strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early menarche and late menopause</span></span></strong></em></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Obesity</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>DM</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Tamoxifen</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Atypical Endometrial hyperplasia</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Unopposed estrogen exposure&nbsp;</em></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>PCOS</em></strong></span></span></li>\r\n\t\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Granulosa cell ovarian tumor</em></strong></span></span></li>\r\n\t\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>HRT with only estrogen</em></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Genetic syndromes like Lynch syndrome (HNPCC) and Cowden syndrome</em></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek &amp; Novak, 16 ed, page 2362</span></strong></span></span></p>",
    "correct_choice_id": 75897,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 18986,
    "choices": [
      {
        "id": 75904,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karman canulla</span></span></span></p>"
      },
      {
        "id": 75905,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manual vacuum aspiration cannula</span></span></span></p>"
      },
      {
        "id": 75906,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pipelle endometrial aspiration cannula</span></span></span></p>"
      },
      {
        "id": 75907,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine sound </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Identify the instrument given below:</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture2.jpg\" style=\"height:273px; width:300px\" /></span></span></p>",
    "unique_key": "Q2240885",
    "question_audio": null,
    "question_video": null,
    "map_id": 31021,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Pipelle endometrial aspiration cannula</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">This is an office endometrial aspiration cannula available as many names like pipelle and the vibra aspirator</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">It is used to procure an endometrial aspirate as an OPD procedure as the cannula is so thin, it does not usually require cervical dilatation</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">This procedure is done in women with Abnormal Uterine Bleeding (AUB)</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">The other ways to obtain an endometrial sample for HPE is by</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hysteroecopic guided endometrial biopsy (Gold standard)</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dilatation and curettage&nbsp;</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Other Options:</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Option A: Karmans cannula:</strong> These are disposable plastic cannulas which are color coded dependng on their diameter and appear as shown below. They are used as aspiration cannulas which are attached to an manual vacuum aspirator and are used to aspirate products of conception.&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><img alt=\"Karman Cannula, Karman Cannula with Universal Adoptor, Karman Cannula  without Universal Adopter\" src=\"https://www.mediplusindia.com/wp-content/uploads/2017/10/mi1.jpg\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option B: Manual Vacuum Aspirator. </strong>This is attached to the Karman cannula and the vauum created is used in suction evacuation to aspirate products of conception</li>\r\n</ul>\r\n\r\n<p><img alt=\"White MVA Syringe, For Hospital And Laboratory\" src=\"https://5.imimg.com/data5/XU/RN/MY-2413456/mva-syringe.jpg\" /></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Option D: Uterine Sound: </strong>This is a slightly curved metal instrument used to measure the length of the uterine cavity in procedures like a D&amp;C or during insertion of an intra-uterine device</span></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217215354-1.png\" style=\"height:192px; width:204px\" /></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>An endometrial biopsy can be taken by</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Hysteroscopy guided endometrial biopsy (Gold standard)</strong></em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Dilatation and curettage</strong></em></span></li>\r\n\t<li><span style=\"font-size:14px\"><strong><em>Office endometrial aspiration in the OPD&nbsp;</em></strong></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref :&nbsp; </strong><a href=\"https://www.semanticscholar.org/paper/Frequency-of-Positive-Endometrial-Pipelle-Biopsies-Zaman-Jabeen/30747f41d85e5bbb4783e846377d979c77102785\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://www.semanticscholar.org/paper/Frequency-of-Positive-Endometrial-Pipelle-Biopsies-Zaman-Jabeen/30747f41d85e5bbb4783e846377d979c77102785</strong></a></span></span></p>",
    "correct_choice_id": 75906,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 18987,
    "choices": [
      {
        "id": 75908,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial aspiration cannula for endometrial sampling</span></span></span></p>"
      },
      {
        "id": 75909,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karman cannula for RPOC</span></span></span></p>"
      },
      {
        "id": 75910,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manual Vacuum aspiration for missed abortion</span></span></span></p>"
      },
      {
        "id": 75911,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suction evacuation for molar pregnancy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">What procedure is done with the given instrument:</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture4.jpg\" style=\"height:258px; width:350px\" /></span></span></p>",
    "unique_key": "Q3879809",
    "question_audio": null,
    "question_video": null,
    "map_id": 31022,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Endometrial aspiration cannula for endometrial sampling</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture5.jpg\" style=\"height:143px; width:500px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>This is an office endometrial aspiration cannula available as many names like pipelle and the vibra aspirator</li>\r\n\t<li>It is used to procure an endometrial aspirate as an OPD procedure as the cannula is so thin, it does not usually require cervical dilatation</li>\r\n\t<li>This procedure is done in women with Abnormal Uterine Bleeding (AUB)</li>\r\n\t<li>The other ways to obtain an endometrial sample for HPE is by\r\n\t<ul>\r\n\t\t<li>Hysteroecopic guided endometrial biopsy (Gold standard)</li>\r\n\t\t<li>Dilatation and curettage</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option B:</strong> Karman cannula for RPOC:&nbsp;</span></span></span>These are disposable plastic cannulas which are color coded dependng on their diameter and appear as shown below. They are used as aspiration cannulas which are attached to an manual vacuum aspirator and are used to aspirate products of conception.</li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217220652-1.jpeg\" style=\"height:212px; width:238px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option C:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manual Vacuum aspiration for missed abortion. A Manual Vacuum Aspiratior (MVA)&nbsp;</span></span></span>&nbsp;is attached to the Karman cannula and the vauum created is used in suction evacuation to aspirate products of conception</li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217220836-1.jpeg\" style=\"height:231px; width:218px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option D:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suction evacuation for molar pregnancy: Suction evacuation for molar pregnancy is usually done by a manual vacuum aspiration syringe as shown above or with an electrical vacuum aspiration in which the Karmans cannula is attached to an electrical suction machine</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture5.jpg\" style=\"height:143px; width:500px\" /></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li>This is an office endometrial aspiration cannula available as many names like pipelle and the vibra aspirator</li>\r\n\t<li>It is used to procure an endometrial aspirate as an OPD procedure as the cannula is so thin, it does not usually require cervical dilatation</li>\r\n\t<li>This procedure is done in women with Abnormal Uterine Bleeding (AUB)</li>\r\n\t<li>The other ways to obtain an endometrial sample for HPE is by\r\n\t<ul>\r\n\t\t<li>Hysteroecopic guided endometrial biopsy (Gold standard)</li>\r\n\t\t<li>Dilatation and curettage</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: </strong><a href=\"https://www.semanticscholar.org/paper/Office-endometrial-sampling%3A-a-comparison-between-4-Zutshi-Gupta/25eacdc961e0fae8cb8414abee5961eed481c2f0\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://www.semanticscholar.org/paper/Office-endometrial-sampling%3A-a-comparison-between-4-Zutshi-Gupta/25eacdc961e0fae8cb8414abee5961eed481c2f0</strong></a></span></span></p>",
    "correct_choice_id": 75908,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "InstrumentsBased"
    ]
  },
  {
    "id": 18989,
    "choices": [
      {
        "id": 75916,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial Carcinoma</span></span></span></p>"
      },
      {
        "id": 75917,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial hyperplasia</span></span></span></p>"
      },
      {
        "id": 75918,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molar pregnancy</span></span></span></p>"
      },
      {
        "id": 75919,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retained product of conception</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman visits OPD with heavy menstrual bleeding. Her USG is shown below Histopathology shows dilated cystic glands with increased gland: stroma ratio. The probable diagnosis is:</span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture6.jpg\" style=\"height:231px; width:350px\" /></span></span></p>",
    "unique_key": "Q8846957",
    "question_audio": null,
    "question_video": null,
    "map_id": 31023,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Endometrial hyperplasia</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Endometrial&nbsp;hyperplasia is a condition where there is endometrial thickening. It can be simple pr complex and with or without atypia. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Simple hyperplasia is characterized by dilated or cystic glands with round to slightly irregular shapes, an increased glandular-to-stromal ratio without glandular crowding</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Complex hyperplasia has architecturally complex (budding and infolding) crowded glands, with less intervering stroma</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Atypical hyperplasia refers to cytologic atypia and is a high risk for endometrial carcinoma</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other Options</span></span></span></span></strong></em></p>\r\n\r\n<ol>\r\n\t<li><strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\"><span dir=\"ltr\" lang=\"EN-IN\"><span style=\"color:black\">Option A: Endometrial cancer:</span></span></span></span></strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\"><span dir=\"ltr\" lang=\"EN-IN\"><span style=\"color:black\"> In this the HPE will show features of carcinoma including&nbsp; c</span></span>ellular / nuclear enlargement, nuclear rounding with large nucleoli, loss of polarity and cytoplasmic eosinophilia</span></span></li>\r\n\t<li><strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Option C: Molar Pregnancy: </span></span></strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">The USG image will show snowstorm appearance and the HPE will show, trophoblastic hyperplasia and villous edema</span></span></li>\r\n\t<li><strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Option D: </span></span></strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Retained products of conception: This will appear as trophoblastic tissue on microscopy</span></span></li>\r\n</ol>\r\n\r\n<p><em><span style=\"font-size:14px\"><strong>Educational Objective:&nbsp;</strong></span></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Endometrial&nbsp;hyperplasia is a condition where there is endometrial thickening. It can be simple pr complex and with or without atypia. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Simple hyperplasia is characterized by dilated or cystic glands with round to slightly irregular shapes, an increased glandular-to-stromal ratio without glandular crowding</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Complex hyperplasia has architecturally complex (budding and infolding) crowded glands, with less intervering stroma</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Atypical hyperplasia refers to cytologic atypia and is a high risk for endometrial carcinoma</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: berek &amp; novak, 16 ed, page 2364</span></strong></span></span></p>",
    "correct_choice_id": 75917,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 18991,
    "choices": [
      {
        "id": 75924,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CA 125</span></span></span></p>"
      },
      {
        "id": 75925,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial aspiration biopsy</span></span></span></p>"
      },
      {
        "id": 75926,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear</span></span></span></p>"
      },
      {
        "id": 75927,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prepare for hysterectomy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">55-year-old post-menopausal woman presents to OPD with post-menopausal bleeding. Her USG shows endometrial thickness of 7mm. Next step in management is:</span></span></p>",
    "unique_key": "Q7713994",
    "question_audio": null,
    "question_video": null,
    "map_id": 31024,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Endometrial aspiration biopsy</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">After physical and pelvic examination, the first test to evaluate for signs of endometrial cancer is transvaginal ultrasound</span></span></span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">If the endometrial thickness in a post menopausal woman is </span></span>&ge; 5mm, an endometrial biopsy should be done.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">An endometrial biopsy can be obtained by</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Office endomtrial aspiration</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dilatation and curettage</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hysteroscopy and biopsy (Gold standard)</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>\r\n\t<ul>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Other Options:&nbsp;</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option A:</strong>&nbsp;CA 125: This is a marker for epithelial ovarian cancer</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option C:</strong> Pap smear: This is a screening test for cervical cancer. In the queston it is already mentioned that the endometrium is thickened so taking a pap smear will not be the net best step</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option D:</strong> Prepare for a hysterectomy: Am endometrial biopsy is required an only if there is endometrial hyperplasia with atypia or if ther eis endometrial carcinoma, should a hysterectomy be done</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Educational Objective:&nbsp;</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">After physical and pelvic examination, the first test to evaluate for signs of endometrial cancer is transvaginal ultrasound</span></span></span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">If the endometrial thickness in a post menopausal woman is </span></span>&ge; 5mm, an endometrial biopsy should be done.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">An endometrial biopsy can be obtained by</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Office endomtrial aspiration</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dilatation and curettage</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hysteroscopy and biopsy (Gold standard)</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: figo cancer report, 2021</span></strong></span></span></p>",
    "correct_choice_id": 75925,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 18994,
    "choices": [
      {
        "id": 75936,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ovaries should be conserved</span></span></p>"
      },
      {
        "id": 75937,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ovaries should be removed</span></span></p>"
      },
      {
        "id": 75938,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ovaries can be removed if they appear pathological</span></span></p>"
      },
      {
        "id": 75939,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ovaries should be conserved if patient is pre-menopausal and should be removed if patient is post-menopausal </span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 49-year-old woman with biopsy proven endometrial cancer and MRI showing endometrial growth involving more than 50% myometrium is undergoing hysterectomy. What will be your advice regarding removal of ovaries?</span></span></p>",
    "unique_key": "Q3800665",
    "question_audio": null,
    "question_video": null,
    "map_id": 31025,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Ovaries should be removed</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient probably has an endometrial cancer which has infilterated into the myometrium</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">The recommended standard surgical procedure is an extra-fascial total hysterectomy with bilateral salpingo-oophorectomy. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Adnexal removal is recommended even if the tubes and ovaries appear normal, as they may contain micrometastases. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">In premenopausal women with low-grade, early-stage disease, ovarian preservation could be considered</span></span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">&nbsp;</span></span></span></span></span></li>\r\n\t<li><em><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">Vaginal cuff removal is not advised, nor is there any benefit from excising parametrial tissue in the usual case.&nbsp;</span></span></span></span></span></em></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14px\"><strong><em>Educational Objective:&nbsp;</em></strong></span></p>\r\n\r\n<p><em><strong><span style=\"font-size:14px\">The recommended surgical procedure in endometrial cancer </span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">is an extra-fascial total hysterectomy with bilateral salpingo-oophorectomy.</span></span></span></span></span></strong></em></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Figo cancer report 2021</span></strong></span></span></p>",
    "correct_choice_id": 75937,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased"
    ]
  },
  {
    "id": 18995,
    "choices": [
      {
        "id": 75940,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">The patient has stage IIIb disease </span></span></p>"
      },
      {
        "id": 75941,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">No further treatment required as lymphadenectomy already done</span></span></p>"
      },
      {
        "id": 75942,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Lymphadenectomy in endometrial cancer helps in staging and guiding further management </span></span></p>"
      },
      {
        "id": 75943,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">The patient will require adjuvant vaginal brachytherappy</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman underwent hysterectomy with bilateral salpingooophorectomy with pelvic and para-aortic lymphadenectomy for endometrial cancer. Histopathology confirms lymph node involvement.&nbsp; Which of the following statements is correct: </span></span></p>",
    "unique_key": "Q1144376",
    "question_audio": null,
    "question_video": null,
    "map_id": 31026,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Lymphadenectomy in endometrial cancer helps in staging and guiding further management </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient has stage IIIc disease as per FIGO staging and&nbsp; she will require complete surgical resection (TAH + BSO with pelvic and para-aortic lymphadenectomy) followed by post operative adjuvant EBRT +/- chemotherapy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Lymphadenectomy is required for accurate staging and is considered a staging procedure. Its potential therapeutic benefits are mainly contribution to accurate indication for adjuvant therapy.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Most patients presenting with Stage&nbsp;III endometrial cancer are managed by complete surgical resection of all pelvic and/or nodal disease, followed by postoperative EBRT and/or chemotherapy.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><em><strong><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">Other Options:&nbsp;</span></span></strong></em></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\"><strong>Option A:</strong>&nbsp;</span></span>The patient has stage IIIb disease: involvement of pelvic and para-aortic lymoh node involvement means stage III-C</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option B:&nbsp;</strong>No further treatment required as lymphadenectomy already done: Treatment of endocmtrial canncer is surgery f/b radiotherapy or chemotherapy. Only in very early stages with log grade tumor (Stage 1A1) is surgery sufficient</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option D:</strong>&nbsp;The patient will require adjuvant vaginal brachytherappy: Folowing surgery for endomatrial cancer, radiotherapy is given as external beam radiotherapy (EBRT) and not brachytherapy</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Educational Objective:&nbsp;</span></span></span></span></span></strong></em></p>\r\n\r\n<p><img alt=\"Image\" src=\"https://pbs.twimg.com/media/FzFlF3IWAAUU5Rn?format=jpg&amp;name=900x900\" /></p>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Figo cancer report 2021</span></span></span></strong></em></p>",
    "correct_choice_id": 75942,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 18996,
    "choices": [
      {
        "id": 75944,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type I endometrial cancer: due to unopposed estrogen</span></span></p>"
      },
      {
        "id": 75945,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type I endometrial cancer: due to unopposed progesterone</span></span></p>"
      },
      {
        "id": 75946,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type II endometrial cancer: due to unopposed estrogen</span></span></p>"
      },
      {
        "id": 75947,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type II endometrial cancer: due to unopposed progesterone</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In relation to endometrial cancer which of the following is CORRECT:</span></span></p>",
    "unique_key": "Q1966014",
    "question_audio": null,
    "question_video": null,
    "map_id": 31027,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Type I endometrial cancer: due to unopposed estrogen</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial cancer is of 2 types: Type 1 (endometroid) and type 2 (non endometroid)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I endometrial cancers occur in women with history of exposure to unopposed estrogen. Type II endometrial carcinoma are estrogen independent tumors. </span></span></span></li>\r\n</ul>\r\n\r\n<p><img alt=\"Different characteristics of type 1 and type 2 endometrial cancer |  Download Table\" src=\"https://www.researchgate.net/publication/268335090/figure/tbl2/AS:686347681542145@1540649447437/Different-characteristics-of-type-1-and-type-2-endometrial-cancer.png\" /></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><img alt=\"Different characteristics of type 1 and type 2 endometrial cancer |  Download Table\" src=\"https://www.researchgate.net/publication/268335090/figure/tbl2/AS:686347681542145@1540649447437/Different-characteristics-of-type-1-and-type-2-endometrial-cancer.png\" /></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek &amp; novak, 16 edition, page 2362</span></strong></span></span></p>",
    "correct_choice_id": 75944,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19000,
    "choices": [
      {
        "id": 75960,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Endometroid</span></span></p>"
      },
      {
        "id": 75961,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Endometroid with squamous differenciation</span></span></p>"
      },
      {
        "id": 75962,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Mucinous</span></span></p>"
      },
      {
        "id": 75963,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Serous&nbsp; </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following type of endometrial cancer type has worst prognosis?</span></span></p>",
    "unique_key": "Q1014247",
    "question_audio": null,
    "question_video": null,
    "map_id": 31028,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Serous</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serous carcinomas are hgh risk lesions. They are a type of type 2 (non endometrioid) endometrial cancers and are more aggressive and have worese prognosis complared to type 1 cancers.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/image.png\" style=\"height:281px; width:501px\" /></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/image_A9fgwQi.png\" style=\"height:281px; width:501px\" /></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and novak, 16ed, page 2378</span></strong></span></span></p>",
    "correct_choice_id": 75963,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19001,
    "choices": [
      {
        "id": 75964,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Cervical and ovarian</span></span></p>"
      },
      {
        "id": 75965,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Cervical and GTN</span></span></p>"
      },
      {
        "id": 75966,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Endometrial and cervical </span></span></p>"
      },
      {
        "id": 75967,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Endometrial and ovarian cancer</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common simultaneously occurring malignancies are:</span></span></p>",
    "unique_key": "Q6001566",
    "question_audio": null,
    "question_video": null,
    "map_id": 31029,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Endometrial and ovarian</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronous endometrial and ovarian tumors are the most frequent simultaneously occurring genital tract malignancies. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian granulosa cell tumors are frequenctly associated with endometrial hyperplasia and cancer due to unpoosed estrogen exposur</span></span></span>e</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronous endometrial and ovarian tumors are the most frequent simultaneously occurring genital tract malignancies.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and novak, 16ed, page 2381</span></strong></span></span></p>",
    "correct_choice_id": 75967,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 19022,
    "choices": [
      {
        "id": 76048,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1: d, 2: b, 3: a, 4: c </span></span></p>"
      },
      {
        "id": 76049,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1: b, 2: d, 3: a, 4: c</span></span></p>"
      },
      {
        "id": 76050,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1: a, 2: c, 3: b, 4: d</span></span></p>"
      },
      {
        "id": 76051,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1: c, 2: a, 3: b, 4: d</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the ovarian tumors with the type of cell they resemble: </span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-745.jpg\" style=\"height:148px; width:700px\" /></p>",
    "unique_key": "Q5484104",
    "question_audio": null,
    "question_video": null,
    "map_id": 31042,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. 1: b, 2: d, 3: a, 4: c</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-746.jpg\" style=\"height:199px; width:900px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong>The histologic picture of different epithelial ovarian cancers resempble different epithelium as shown in the table below:</strong></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-746.jpg\" style=\"height:199px; width:900px\" /></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak 16 ed, page 2547</strong></span></span></p>",
    "correct_choice_id": 76049,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 19025,
    "choices": [
      {
        "id": 76060,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1b &nbsp;2a &nbsp;3d &nbsp;4c</span></span></p>"
      },
      {
        "id": 76061,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1a &nbsp;2b &nbsp;3d &nbsp;4c </span></span></p>"
      },
      {
        "id": 76062,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1d &nbsp;2c &nbsp;3a &nbsp;4b</span></span></p>"
      },
      {
        "id": 76063,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1c &nbsp;2d &nbsp;3b &nbsp;4a</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-122614.jpg\" style=\"height:233px; width:700px\" /></p>",
    "unique_key": "Q7430236",
    "question_audio": null,
    "question_video": null,
    "map_id": 31044,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: A. 1b&nbsp; 2a&nbsp; 3d&nbsp; 4c</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-122712.jpg\" style=\"height:239px; width:700px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:</strong></em></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-122043.jpg\" style=\"height:800px; width:700px\" /></strong></em></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Important HPE images in ovarian cancer:&nbsp;</strong></em></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: berek and novak, 16 ed, chapter 39</strong></span></span></p>",
    "correct_choice_id": 76060,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19032,
    "choices": [
      {
        "id": 76088,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inability to prove ovarian malignancy by histopathology before staging laparotomy</span></span></p>"
      },
      {
        "id": 76089,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inability to attain complete cytoreduction during surgery</span></span></p>"
      },
      {
        "id": 76090,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inability to start chemotherapy within 2 weeks of surgery</span></span></p>"
      },
      {
        "id": 76091,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Need to perform resection anastomosis of bowel to achieve complete cytoreduction </span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents to you with ovarian malignancy. Her CA 125 is 850 U/mL. Her MRI shows 15cm*15 cm ovarian mass along with omental caking. She is planned for staging laparotomy and adjuvant chemotherapy. Which of the following will have worst effect on the prognosis of the patient? </span></span></p>",
    "unique_key": "Q7708418",
    "question_audio": null,
    "question_video": null,
    "map_id": 31045,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. Inability to attain complete cytoreduction during surgery</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Complete cytoreduction is the most important factor associated with survival in advanced ovarian cancers. Need for Resection anastomosis does not worsen prognosis</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Other Options</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A: </strong>Histopathological diagnosis is not required before staging laparotomy </span></span></li>\r\n\t<li><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Option B:&nbsp; </span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Overall survival has been founf to be less if time to chemotherapy was after 8 weeks following cytoreductive surgery</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:&nbsp;</strong>Need to perform resection anastomosis of bowel to achieve complete cytoreduction.&nbsp;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">An analysis of the retrospective data indicates that, &nbsp;Intestinal resection does not appear to increase the overall morbidity caused by the operation.&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Educational Objective:&nbsp;</span></span></strong></em></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Complete cytoreduction is the most important factor associated with survival in advanced ovarian cancers. Need for Resection anastomosis does not worsen prognosis</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak 16 edition, page 2589</strong></span></span></p>",
    "correct_choice_id": 76089,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19033,
    "choices": [
      {
        "id": 76092,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1b 2d 3c 4a</span></span></p>"
      },
      {
        "id": 76093,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1b 2c 3d 4a</span></span></p>"
      },
      {
        "id": 76094,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1a 2c 3b 4d</span></span></p>"
      },
      {
        "id": 76095,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1a 2d 3c 4b</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following: </span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-751.jpg\" style=\"height:184px; width:700px\" /></p>",
    "unique_key": "Q4837438",
    "question_audio": null,
    "question_video": null,
    "map_id": 31046,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans: B. 1b 2c 3d 4a</span></span></strong></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember the table for ovarian tumor markers. It is very very important</span></span></strong></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-752.jpg\" style=\"height:276px; width:900px\" /></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember the table for ovarian tumor markers. It is very very important</span></span></strong></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-752.jpg\" style=\"height:276px; width:900px\" /></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek and novak 16 ed, chapter 39</strong></span></span></p>",
    "correct_choice_id": 76093,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 19035,
    "choices": [
      {
        "id": 76100,
        "text": "<p><span style=\"font-size:12pt;\">Call exner bodies are present</span></p>"
      },
      {
        "id": 76101,
        "text": "<p><span style=\"font-size:12pt;\">Highly chemosensitive</span></p>"
      },
      {
        "id": 76102,
        "text": "<p><span style=\"font-size:12pt;\">Level of Inhibin B is raised</span></p>"
      },
      {
        "id": 76103,
        "text": "<p><span style=\"font-size:12pt;\">Precocious puberty is due to associated adrenal tumors</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old girl presents with precocious puberty and solid ovarian mass suspected to be granulosa cell tumor. Which of the following is false regarding these tumors:</span></p>",
    "unique_key": "Q2467324",
    "question_audio": null,
    "question_video": null,
    "map_id": 31048,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D. Precocious puberty is due to associated adrenal tumors</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Precocious purberty is due to secretion of estrogen by tumor as these tumors secrete estrogen. Hence these tumors commonly present as precociuos puberty or abnormal uterine bleeding</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A: </strong>Call Exner bodies are characteristically seen in Granulosa cell tumors on HPE</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B:&nbsp;</strong>Highly chemosensitive: Granulosa cell tumors are highly chemosensitive. The chemotherapeutic regime of choice is the BEP&nbsp;regimen (Bleomycin, Etoposide, Cisplatin).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:&nbsp;</strong>Level of Inhibin B is raised: Levels of Inhibin (A&amp; B), Estradiol and AMH are raised in grabulosa cell tumor.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Granulosa Cell Tumor of the Ovary:</strong>&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Granulosa cell tumors:&nbsp;2 percent of all ovarian neoplasms.</span></li><li><span style=\"font-size:16px;\">Originates from the \u2018rests\u2019 of primitive granulosa cells unused in folliculogenesis.</span></li><li><span style=\"font-size:16px;\">It is the commonest ovarian stromal tumor.</span></li><li><span style=\"font-size:16px;\">It is bilateral&nbsp;in 2%&nbsp;</span></li><li><span style=\"font-size:16px;\">The size varies, so also the consistency \u2014 may be solid or cystic.</span></li><li><span style=\"font-size:16px;\">Cut section: yellow or orange&nbsp;due to its lipid content.</span></li><li><span style=\"font-size:16px;\">Microscopic appearance:&nbsp;</span><ul><li><span style=\"font-size:16px;\">Coffee bean\u201d nuclei. S</span></li><li><span style=\"font-size:16px;\">Call-Exner bodies: Pathognomonic of granulosa cell tumor.</span></li></ul></li><li><span style=\"font-size:16px;\">The&nbsp;tumor cells secrete inhibin, estrogen and AMH (tumor markers)</span></li><li><span style=\"font-size:16px;\">As the tumor produces estrogen, there may be associated endometrial hyperplasia (50%) and unopposed estrogenic stimulation leads to development of endometrial carcinoma in about 5\u201310 percent of cases.</span></li><li><span style=\"font-size:16px;\">Clinical features:&nbsp;</span><ul><li><span style=\"font-size:16px;\">It occurs in all ages, 10 percent prior to puberty, 40 percent during childbearing period and 50 percent in postmenopausal women.</span></li><li><span style=\"font-size:16px;\">Prior to puberty: Precocious puberty</span></li><li><span style=\"font-size:16px;\">Childbearing period: Abnormal uterine bleeding</span></li><li><span style=\"font-size:16px;\">Postmenopausal: Bleeding</span></li></ul></li><li><span style=\"font-size:16px;\">Treatment: Laparotomy and surgical staging followed by chemotherapy is done.&nbsp;Unilateral salpingo-oophorectomy is the optimum treatment for children or women in the reproductive age. &nbsp;BEP (Bleomycin, Etoposide and Cisplatin) is the chemotherapeutic regimens. It is a highly chemosensitive tumor.&nbsp; Overall prognosis is good. Life time follow up is essential as recurrence can occur as late as 30 years</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Berek &amp; novak, 16 ed, page 2646</strong></span></p>",
    "correct_choice_id": 76103,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19042,
    "choices": [
      {
        "id": 76128,
        "text": "<p><span style=\"font-size:12pt;\">Offer BRCA testing</span></p>"
      },
      {
        "id": 76129,
        "text": "<p><span style=\"font-size:12pt;\">Offer bilateral salpingooophorectomy</span></p>"
      },
      {
        "id": 76130,
        "text": "<p><span style=\"font-size:12pt;\">Offer CA 125 measurement</span></p>"
      },
      {
        "id": 76131,
        "text": "<p><span style=\"font-size:12pt;\">Offer bilateral mastectomy</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 30-year-old woman presents to you as she recently found out that her aunt passed away from breast cancer. Her mother had passed away from ovarian cancer 10 years of ago. What is the next best step:</span></p>",
    "unique_key": "Q1047142",
    "question_audio": null,
    "question_video": null,
    "map_id": 31039,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A. Offer BRCA testing</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This woman has 2 affected members, therefore the first step is testing for BRCA mutation, further management of salpingooophorectomy/mastectomy/ surveillance will depend on presence/absence of BRCA gene, her fertility and desire for further childbearing.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B:&nbsp;</strong>Offer bilateral salpingooophorectomy: This can be offered if BRCA is positive and once child bearing is complete</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong>&nbsp;Offer CA 125 measurement: Ca 125 is to assess the risk of malignancy in a woman with an adnexal mass. </span><span style=\"background-color:transparent;font-size:16px;\">Only after she has been diagnosed with ovarian cancer is the ca 125 helpful.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D:&nbsp;</strong>Offer bilateral mastectomy: In women with BRCA positive, b/l mastectomy can be offered.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>BRCA testing should be offered to women with:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-162846.jpg\" alt=\"\" width=\"1000\" height=\"474\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Berek and novak, 16 ed 2564</strong></span></p>",
    "correct_choice_id": 76128,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 19052,
    "choices": [
      {
        "id": 76168,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical history of passage of clear vesicles</span></span></span></p>"
      },
      {
        "id": 76169,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histological features showing hydropic changes in villi/ trophoblastic proliferation</span></span></span></p>"
      },
      {
        "id": 76170,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased beta hCG levels </span></span></span></p>"
      },
      {
        "id": 76171,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound feature of snowstorm appearance</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents to emergency with amenorrhea, bleeding and passage of clear vesicles. She undergoes suction evacuation. The definitive diagnosis of molar pregnancy is made by:</span></span></span></p>",
    "unique_key": "Q1910807",
    "question_audio": null,
    "question_video": null,
    "map_id": 31041,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Histological features showing hydropic changes in villi/ trophoblastic proliferation</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">The definitive diagnosis of a molar pregnancy is made by histological examination.</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPE features consistent with the diagnosis of complete molar pregnancies include:</span></span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Absence of fetal tissue</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Extensive hydropic change to the villi</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Excess trophoblast proliferation. </span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPE Features of a partial molar pregnancy include: </span></span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Presence of fetal tissue&nbsp;&nbsp;&nbsp;</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Focal hydropic change to the villi</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Excess trophoblast proliferation</span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ploidy status and immunohistochemistry staining for&nbsp;</span></span></span><em><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">p57</span></span></em><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, a paternally imprinted gene, may help in distinguishing partial from complete molar pregnancies.</span></span></span></span></span></p>\r\n\r\n<p><em><strong>Other Options:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li><em><strong>Option A:&nbsp;</strong></em><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical history of passage of clear vesicles: Although this is highly suggestive of complete mole, confirmation is only on HPE</span></span></span></li>\r\n\t<li><strong>Option B:</strong>&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased beta hCG levels: Molar pregnancy is associated with very high bhCG levels but again is not conformatory of molar pregnancy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C:</strong> Snowstorm appearance on ultrasound: This is the classical picture on ultrasoud of complete mole&nbsp;but again is not conformatory of molar pregnancy</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPE features consistent with the diagnosis of complete molar pregnancies include:</span></span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Absence of fetal tissue</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Extensive hydropic change to the villi</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Excess trophoblast proliferation. </span></span></span></span></span>\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPE Features of a partial molar pregnancy include: </span></span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Presence of fetal tissue&nbsp;&nbsp;&nbsp;</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Focal hydropic change to the villi</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Excess trophoblast proliferation</span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<h1><strong><span style=\"font-size:24pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Management of Gestational Trophoblastic Disease</span></span></span></span></span></strong></h1>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Green-top Guideline No. 38 &ndash; June 2020</span></span></strong></span></span></p>",
    "correct_choice_id": 76169,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19055,
    "choices": [
      {
        "id": 76180,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Complete abortion</span></span></span></span></p>"
      },
      {
        "id": 76181,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Complete mole</span></span></span></span></p>"
      },
      {
        "id": 76182,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Incomplete abortion</span></span></span></span></p>"
      },
      {
        "id": 76183,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Partial mole</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">A 19-year-old primigravida presents to OPD with amenorrhea of 2.5 months, positive urine pregnancy test and bleeding per vagina. Her ultrasound image is shown below. She is most likely a case of: </span></span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/3_4G8fevK.jpg\" style=\"height:233px; width:350px\" /></span></span></span></p>",
    "unique_key": "Q7788379",
    "question_audio": null,
    "question_video": null,
    "map_id": 31043,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ans. B. Complete mole</span></span></strong></span></span></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_Rs9hSOQ.png\" style=\"height:275px; width:392px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>In complete mole the characteristic USG picture is as shown and is called as snowstorm appearance</li>\r\n\t<li>In partial mole, the snowstorm appearance is not typically seen; fetal parts will be seen</li>\r\n</ul>\r\n\r\n<p><em><strong>Other Options:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li><em><strong>Option A: Complete Abortion:</strong></em> On ultrasound, an empty uterus is seen</li>\r\n\t<li><em><strong>Option C: Incomplete abortion:</strong></em> On ultrasound, retained products of conception are seen</li>\r\n\t<li><em><strong>Option D: Partial mole:</strong></em> On ultrasound, fetal parts may be seen. Typical snowstorm pattern is not seen</li>\r\n</ul>\r\n\r\n<p><em><strong>Educational Objective:&nbsp;</strong></em></p>\r\n\r\n<p><strong>The characteristic feature on ultrasound of a complete mole is as shown: SNOWSTORM APPEARANCE</strong></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_Rs9hSOQ.png\" style=\"height:275px; width:392px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ref: William&rsquo;s obstetrics, 26<sup>th</sup> edition, chapter 13, </span></span></strong></span></span></p>",
    "correct_choice_id": 76181,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 19098,
    "choices": [
      {
        "id": 76352,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XX, of maternal and paternal origin</span></span></span></p>"
      },
      {
        "id": 76353,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XX, of paternal origin only</span></span></span></p>"
      },
      {
        "id": 76354,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">69XXY, of maternal and paternal origin</span></span></span></p>"
      },
      {
        "id": 76355,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">69XXY, of paternal origin only</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20 year old woman undergoes suction evacuation for molar pregnancy. Histopathology features are suggestive of complete mole. Regarding karyotype of the tissue, which of the following is most likely:</span></span></p>",
    "unique_key": "Q5590203",
    "question_audio": null,
    "question_video": null,
    "map_id": 31047,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. 46XX of paternal origin only</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complete mole: The molar chromosomes are entirely of paternal origin. They usually have a 46XX karyotype, about 10% have 46XY karyotype. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><em><strong>Option A:&nbsp;</strong></em><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XX, of maternal and paternal origin: This is wrong as complete mole has only paternal origin</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><em><strong>Option C:</strong></em>&nbsp;69XXY, of maternal and paternal origin: This is wrong as complete mole is DIPLOID and is of paternal origin only</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><em><strong>Option D:</strong></em> 69XXY of paternal origin only: This is wrong as complete mole is DIPLOID</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><em><strong>Educational Objective:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">Partial moles are always <strong>TRIPLOD (69XXX/ 69 XXY)</strong></span></span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">2 sperm fertilize one ova </span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">The paternal contribution is called <strong>diandry</strong></span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">Hence <strong>both maternal and paternal component</strong> present in partial mole</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">Usually, 69XXX or 69XXY</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">Complete moles are <strong>DIPLOID</strong></span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication &ndash; this is called <strong>androgenesis OR&nbsp;</strong></span></span></span></span><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">2 sperms (dispermy) fertilize an empty/ inactivated ovum&nbsp;</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">46XX or 46XY&nbsp;</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><strong><span style=\"font-size:11.0pt\"><span style=\"color:black\">Only paternal component;&nbsp;</span></span></strong></span></span><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><strong><span style=\"font-size:11.0pt\"><span style=\"color:black\">No maternal component</span></span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and Novak, 16<sup>th</sup> edition, page 2760</span></strong></span></span></p>",
    "correct_choice_id": 76353,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 19106,
    "choices": [
      {
        "id": 76384,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Decreased</span></span></span></span></span></p>"
      },
      {
        "id": 76385,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Increased </span></span></span></span></span></p>"
      },
      {
        "id": 76386,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Unchanged</span></span></span></span></span></p>"
      },
      {
        "id": 76387,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Can be increased or decreased depending upon complete/ partial mole</span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are posted in gynaecology ward and sending investigations for a woman with molar pregnancy. Her hCG level is &gt;1,00,000. Her TSH levels are likely to be:</span></span></p>",
    "unique_key": "Q6340601",
    "question_audio": null,
    "question_video": null,
    "map_id": 31040,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A. Decreased</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Hyperthyroidism is observed in 7% patients with complete mole.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Elevated free T3, T4 levels and raised TSH is seen in such patients</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This is because of the similarity betwen hCG and TSH so an increased&nbsp;hCG causes increased production of thyroxine and this causes a negative feedback on TSH.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Hyperthyroidism is observed in 7% patients with complete mole.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Elevated free T3, T4 levels and raised TSH is seen in such patients</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This is because of the similarity betwen hCG and TSH so an increased&nbsp;hCG causes increased production of thyroxine and this causes a negative feedback on TSH</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Berek and Novak 16 edition, page 2767</span></span></strong></span></span></span></p>",
    "correct_choice_id": 76384,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 19011,
    "choices": [
      {
        "id": 76004,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complete abortion</span></span></span></p>"
      },
      {
        "id": 76005,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ectopic pregnancy</span></span></span></p>"
      },
      {
        "id": 76006,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incomplete abortion</span></span></span></p>"
      },
      {
        "id": 76007,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molar pregnancy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old woman presents to emergency with complaint of 2 months of amenorrhea with bleeding associated with passage of grape like clear vesicles. The likely diagnosis is:</span></span></span></p>",
    "unique_key": "Q6986448",
    "question_audio": null,
    "question_video": null,
    "map_id": 31052,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Molar pregnancy</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Grossly, complete moles have abnormal chorionic villi that appear as a <strong>mass of clear vesicles</strong>. These vary in size and often hang in clusters from thin pedicles.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The classic presentation of molar pregnancy is a h/o amenorrhoea with a positive UPT with bleeding with passage of typical grape like vesicles&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Option A: Complete Abortion:&nbsp;</strong>Such a patient will present with a h/o amenorrhoea with a h/o bleeding and pain with passage of tissue but now she won&#39;t have any symotoms. On examination, the uterus is normal size and the os is closed.&nbsp;</em></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Option B: Ectopic Pregnancy:</strong> The classic triad of ectopic pregnancy is Abdominal pain + Amenorrhoea + Vaginal Bleeding. In a ruptured ectopic the patient will present with shock.&nbsp;</em></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Option C: Incomplete Abortion:&nbsp;</strong>Such a patient will present with heavy bleeding and pain abdomen with amenorrhoea. On examination, the uterus is less than the period of gestation. The os is open.&nbsp;</em></span></p>\r\n\r\n<p><strong><span style=\"font-size:14px\"><em>Educational Objective:&nbsp;</em></span></strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The classic presentation of molar pregnancy is a h/o amenorrhoea with a positive UPT with bleeding with passage of typical grape like vesicles&nbsp;</span></span></span>\u200b\u200b\u200b\u200b\u200b\u200b\u200b</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: William&rsquo;s obstetrics, 26<sup>th</sup> edition, chapter 13 </span></span></strong></span></span></span></p>",
    "correct_choice_id": 76007,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 19012,
    "choices": [
      {
        "id": 76008,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complete abortion</span></span></span></p>"
      },
      {
        "id": 76009,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ectopic pregnancy</span></span></span></p>"
      },
      {
        "id": 76010,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incomplete abortion</span></span></span></p>"
      },
      {
        "id": 76011,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molar pregnancy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old woman presents to emergency with 3 months amenorrhea and passage of vesicles as shown in image. The woman most likely has:</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/1_KaBmanQ.jpg\" style=\"height:326px; width:450px\" /></span></span></span></p>",
    "unique_key": "Q1037132",
    "question_audio": null,
    "question_video": null,
    "map_id": 31053,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Molar pregnancy</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/2_9PK5kpJ.jpg\" style=\"height:347px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\">The first image is the classical image of grape like vesicles seen in complete molar pregnancy</li>\r\n\t<li style=\"text-align: justify;\">The second image is the HPE of complete molar pregnancy showing diffuse trophoblastic proliferation and diffuse villous edema</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><em><strong>Other Options:</strong></em></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><em><strong>Option A: Complete abortion: </strong>This wont have any characteristic gross image unless it is &gt; 12 weeks where fetal parts will be seen. On HPE there will be chorionic villi</em></li>\r\n\t<li style=\"text-align: justify;\"><em><strong>Option B: Ectopic pregnancy: </strong>On HPE: chorionic villi will be seen</em></li>\r\n\t<li style=\"text-align: justify;\"><em><strong>Option C: Incomplete abortion:</strong>&nbsp;This wont have any characteristic gross image unless it is &gt; 12 weeks where fetal parts will be seen. On HPE there will be chorionic villi</em></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><strong><em>Educational Objective:&nbsp;</em></strong></p>\r\n\r\n<p style=\"text-align:justify\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image.png\" style=\"height:179px; width:515px\" /></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\">The first image is the classical image of grape like vesicles seen in complete molar pregnancy</li>\r\n\t<li style=\"text-align:justify\">The second image is the HPE of complete molar pregnancy showing diffuse trophoblastic proliferation and diffuse villous edema</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: William&rsquo;s obstetrics, 26<sup>th</sup> edition, chapter 13 </span></span></strong></span></span></span></p>",
    "correct_choice_id": 76011,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 19057,
    "choices": [
      {
        "id": 76188,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus infection</span></span></span></p>"
      },
      {
        "id": 76189,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial mole</span></span></span></p>"
      },
      {
        "id": 76190,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rh incompatibility</span></span></span></p>"
      },
      {
        "id": 76191,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Smoking in pregnancy </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient visits for ultrasound at 18 weeks, which shows fetus with syndactyly with multicystic placenta as shown below. The most likely cause is: </span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/5_OvTET0e.jpg\" style=\"height:353px; width:450px\" /></p>",
    "unique_key": "Q3180673",
    "question_audio": null,
    "question_video": null,
    "map_id": 31058,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Partial mole</span></strong></span></span></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_42AWskL.png\" style=\"height:258px; width:367px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">This is the ultrasound image of a partial hydatiform mole in which there are fetal parts (in this image&nbsp;the&nbsp;&nbsp;the fetal head (arrow)) lies adjacent to an enlarged, multicystic placenta&nbsp; </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">When fetus is present in conjunction with partial mole, it usually exhibits the stigmata of triploidy such as growth retardation, syndactyly and hydrocephaly. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option A: </strong>Parvovirus infection in the fetus typically presents as fetal anemia and a hydropic fetus which appears as fetal ascites/ pericardial effusion/ pleural effusion/ scalp or skin edema and an enlarged placenta. A hydropic fetus appears as shown:</em></span></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_lkerIzt.png\" style=\"height:332px; width:467px\" /></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option C: </strong>Rh iso-immunization: In severe fetal anemia, on ultrasound, a hydropic fetus will be seen as shown in the image above</em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option D: </strong>Smoking in pregnancy: Smoking can increase the risk of cleft lip, palate, CNS and CVS anomalies. It is also associated with preterm borth, fetal growth restriction and fetal death.&nbsp;</em></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:14px\"><em>Educational Objective:&nbsp;</em></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\">On ultrasound an complete mole will have a snowstorm pappearance</span></li>\r\n\t<li><span style=\"font-size:14px\">A partial mole will have a cystic looking placenta with partial fetal parts seen</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ref: Berek and Novak, 16<sup>th</sup> edition, page 2762</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">William&rsquo;s obstetrics, 26<sup>th</sup> edition, chapter 13,</span></span></strong></span></span></p>",
    "correct_choice_id": 76189,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 19059,
    "choices": [
      {
        "id": 76196,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ring of Pearls appearance</span></span></span></p>"
      },
      {
        "id": 76197,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rokitansky nodule </span></span></span></p>"
      },
      {
        "id": 76198,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Snowstorm appearance</span></span></span></p>"
      },
      {
        "id": 76199,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Waterlily sign</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the ultrasound finding:</span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/7_UoFonTd.jpg\" style=\"height:232px; width:350px\" /></span></span></p>",
    "unique_key": "Q1392455",
    "question_audio": null,
    "question_video": null,
    "map_id": 31059,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Snowstorm appearance</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The mass is composed of numerous anechoic cystic spaces of different sizes and shapes, but without a fetus or amnionic sac. The appearance is often described as a &ldquo;<strong>snowstorm&rdquo;</strong>. Application of color Doppler displays marked surrounding myometrial vascularity. However, absent internal flow reflects the avascular villi of complete moles. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option A:</strong></em> String of pears appearance is seen in PCOS</span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option B:</strong></em> Roktansky nodule is seen in Mature cystic teratoma or ovarian dermoid</span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option D:</strong></em> Waterlily sign is seen in hydatid cyst</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Educational Objective:&nbsp;</strong></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Snowstorm appearance is characteristically seen in complete mole on ultrasound</strong></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_5smKygV.png\" style=\"height:275px; width:392px\" /></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics, 26 edition, chapter 13.</span></strong></span></span></p>",
    "correct_choice_id": 76198,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 19099,
    "choices": [
      {
        "id": 76356,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XX</span></span></span></p>"
      },
      {
        "id": 76357,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XY</span></span></span></p>"
      },
      {
        "id": 76358,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">69XXX</span></span></span></p>"
      },
      {
        "id": 76359,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">69YYY</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 21-year-old woman presented to emergency with 3 months pregnancy and bleeding per vaginum. She underwent suction evacuation for suspected molar pregnancy. Histopathology confirmed the diagnosis and showed scalloping of chorionic villi. The karyotype is likely to be:</span></span></p>",
    "unique_key": "Q4291403",
    "question_audio": null,
    "question_video": null,
    "map_id": 31061,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. 69 XXX</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scalloping of chorionic villi is suggestive of partial mole. Partial moles have triploid karyotype and amongst the triploid options the best answer is 69 XXX as 69YYY is non-viable gamete. </span></span></span></p>\r\n\r\n<p><em><strong>Other Options:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option A: 46XX: </strong>Partial moles are triploid and hence this is incorrect</em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option B: 46XY:&nbsp;</strong>Partial moles are triploid and hence this is incorrect</em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option D: 69 YYY: </strong>Although this is a triploid karyotype, 69YYY is a non viable gamete</em></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:14px\"><em>Educational Objective:&nbsp;</em></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>Partial moles are always <strong>TRIPLOD (69XXX/ 69 XXY)</strong>\r\n\r\n\t<ul>\r\n\t\t<li>2 sperm fertilize one ova</li>\r\n\t\t<li>The paternal contribution is called <strong>diandry</strong></li>\r\n\t\t<li>Hence <strong>both maternal and paternal component</strong> present in partial mole</li>\r\n\t\t<li>Usually, 69XXX or 69XXY</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>Complete moles are <strong>DIPLOID</strong>\r\n\t<ul>\r\n\t\t<li>Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication &ndash; this is called <strong>androgenesis OR&nbsp;</strong>2 sperms (dispermy) fertilize an empty/ inactivated ovum&nbsp;</li>\r\n\t\t<li>46XX or 46XY&nbsp;</li>\r\n\t\t<li><strong>Only paternal component;&nbsp;</strong><strong>No maternal component</strong></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and&nbsp; Novak 16 edition page 2764 </span></strong></span></span></p>",
    "correct_choice_id": 76358,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 19100,
    "choices": [
      {
        "id": 76360,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy </span></span></span></p>"
      },
      {
        "id": 76361,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterotomy</span></span></span></p>"
      },
      {
        "id": 76362,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suction evacuation</span></span></span></p>"
      },
      {
        "id": 76363,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine artery embolization</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents to emergency ward with 5 months of amenorrhea and bleeding PV, her fundal height is 18 weeks, but external ballotment is absent. USG shown snowstorm appearance. What is the best management option for her: </span></span></p>",
    "unique_key": "Q5663597",
    "question_audio": null,
    "question_video": null,
    "map_id": 31062,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Suction evacuation</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The description given is of a complete mole due to</span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H/o amenorrhea + bleeding</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absent external ballotment</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Snowstorm appearance on ultrasound</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The management of choice in a mplar pregnancy is suction and evacuation, irrespective of the uterine size.</span></span></span></strong></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option A: Chemotherapy:&nbsp;</strong>This is given in gestational trophoblastic neoplasia and not in molar pregnancy.</em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option B: Hysterotomy: </strong>There is no indication of doing a hysterotomy in molar pregnancy, Indications of hysterotomy are a failed medical 2nd trimester abortion</em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option D: Uterine Artery Embolization:&nbsp;</strong>UAE is done in fibroid uterus, Adenomyosis, uterine AV malformation, placenta acrrete syndromes, PPH. It is not indicated in molar pregnancy.&nbsp;</em></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:14px\"><em>Educational Objective:&nbsp;</em></span></strong></p>\r\n\r\n<ul>\r\n\t<li><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The management of choice in a mplar pregnancy is suction and evacuation, irrespective of the uterine size.</span></span></span></strong></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: berek and novak, 16<sup>th</sup> edition: page 2770</span></strong></span></span></p>",
    "correct_choice_id": 76362,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 19103,
    "choices": [
      {
        "id": 76372,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CA 125</span></span></span></p>"
      },
      {
        "id": 76373,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hCG</span></span></span></p>"
      },
      {
        "id": 76374,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibin A</span></span></span></p>"
      },
      {
        "id": 76375,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PAPPA</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following marker is likely to be raised in molar pregnancy:</span></span></p>",
    "unique_key": "Q9754446",
    "question_audio": null,
    "question_video": null,
    "map_id": 31063,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. hCG</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta hCG is a critical marker for GTD and its values are raised in molar pregnancy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta hCG is higher in complete moles (&gt; 100,000) than partial mole</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option A:</strong> Ca125: Ca125 is characteristically highly raised in epithelial ovarian cancers. It is also raised in pregnancy, fibroids, genital TB, PID, fibroids and endometriosis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C:</strong> Inhibin A: Inhibin A and B are raised in granulosa cell tumors of the ovary</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option D:</strong> PAPP-A: A low PAPP-A is associated with a higher incidence of Down syndrome in the fetus, increased risk of FGR, preeclampsia, preterm and fetal demise</span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:&nbsp;</span></span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta hCG is a critical marker for GTD and its values are raised in molar pregnancy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta hCG is higher in complete moles (&gt; 100,000) than partial mole</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: berek and novak, 16<sup>th</sup> edition: page 2757 </span></strong></span></span></p>",
    "correct_choice_id": 76373,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 19104,
    "choices": [
      {
        "id": 76376,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absent in complete mole as it is maternal in origin </span></span></span></p>"
      },
      {
        "id": 76377,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absent in complete mole as it is paternal in origin</span></span></span></p>"
      },
      {
        "id": 76378,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Present in complete mole as it is maternal in origin </span></span></span></p>"
      },
      {
        "id": 76379,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Present in complete mole as it is paternal in origin</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true in relation to P57 immunostaining in molar pregnancy: </span></span></p>",
    "unique_key": "Q2505421",
    "question_audio": null,
    "question_video": null,
    "map_id": 31049,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Absent in complete mole as it is paternal in origin</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">p57KIP2 is a nuclear protein whose gene is paternally imprinted and maternally expressed. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This means that the gene product is produced only in tissues containing a maternal allele. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Because complete moles contain only paternal genes, the p57KIP2 protein is absent in complete moles, and tissues do not pick up this stain. </span></span></span></span></span></li>\r\n\t<li><span style=\"color:#000000; font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>In partial moles as there is a maternal component, p57KIP2 is present</em></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"color:#000000; font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Educational Objective:&nbsp;</em></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">p57KIP2 is a nuclear protein which is maternally expressed and hence present in partial moles (on immunohistochemstry) as partial moles have a maternal component</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is absent in complete moles</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: William&rsquo;s obstetrics 26<sup>th</sup> edition, chapter 13. </span></span></strong></span></span></span></p>",
    "correct_choice_id": 76377,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 19107,
    "choices": [
      {
        "id": 76388,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Fluid overload</span></span></span></span></span></p>"
      },
      {
        "id": 76389,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Metastatic disease suggestive of GTN </span></span></span></span></span></p>"
      },
      {
        "id": 76390,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thyroid storm </span></span></span></span></span></p>"
      },
      {
        "id": 76391,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Trophoblastic embolization</span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman with molar pregnancy is undergoing suction evacuation. Suddenly she develops breathing difficulty, tachypnoea and fall in saturation. The most likely cause is:</span></span></p>",
    "unique_key": "Q2594067",
    "question_audio": null,
    "question_video": null,
    "map_id": 31050,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D. Trophoblastic embolization</span></span></strong></span></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Trophoblastic Embolization</span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Respiratory distress sometimes occurs in patients with a complete mole. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is usually diagnosed in patients with excessive uterine size and markedly elevated</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">T</span></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">hese patients may have chest pain, dyspnea, tachypnea, and tachycardia and may experience severe respiratory distress during and after molar evacuation.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Auscultation of the chest usually reveals diffuse rales, and chest radiographic evaluation may show bilateral pulmonary infiltrates. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Respiratory distress usually resolves within 72 hours with cardiopulmonary support. In some circumstances, patients may require mechanical ventilation.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong>Other Options</strong></em></p>\r\n\r\n<ul>\r\n\t<li><em><strong>Option A:&nbsp;</strong></em><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Fluid overload can present similarly but is unlikely to happen in a suction evacuation. It is more common following hysteroscopic surgeries where excessive fluid gets absorbed leading to pulmonary edema</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Option B:&nbsp;</strong>Metastatic disease suggestive of GTN. This usually would present post suction evacuation when the woman develps GTN. Lung metastases are common (canon ball mets) but this usually presents with cough.&nbsp;</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>O<span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">ption D:&nbsp;</span></span></strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Thyroid storm is seen in complete molar pregnancy due to hyperthyroidism. This usually presents as&nbsp;</span></span></span></span></span></span></span><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">&nbsp;fever,<em> marked tachycardia, heart failure, tremor, nausea and vomiting, diarrhea, dehydration, restlessness, extreme agitation, delirium or coma</em></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><em>Educational Objective:&nbsp;</em></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Respiratory distress sometimes occurs in patients with a complete mole. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is usually diagnosed in patients with excessive uterine size and markedly elevated</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">T</span></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">hese patients may have chest pain, dyspnea, tachypnea, and tachycardia and may experience severe respiratory distress during and after molar evacuation.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Auscultation of the chest usually reveals diffuse rales, and chest radiographic evaluation may show bilateral pulmonary infiltrates. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Respiratory distress usually resolves within 72 hours with cardiopulmonary support. In some circumstances, patients may require mechanical ventilation</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and Novak, 16<sup>th</sup> edition. 2767</span></strong></span></span></p>",
    "correct_choice_id": 76391,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19108,
    "choices": [
      {
        "id": 76392,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Curette</span></span></span></span></span></p>"
      },
      {
        "id": 76393,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Karman cannula</span></span></span></span></span></p>"
      },
      {
        "id": 76394,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Manual vacuum aspiration syringe</span></span></span></span></span></p>"
      },
      {
        "id": 76395,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pipelle suction curette</span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the instrument:</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/8_K4h83MU.jpg\" style=\"height:235px; width:350px\" /></span></span></p>",
    "unique_key": "Q2644657",
    "question_audio": null,
    "question_video": null,
    "map_id": 31051,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B. Karman cannula</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\">These are Karman cannulas</span></li>\r\n\t<li><span style=\"font-size:14px\">They are disposable plastic cannulas which are color coded depending on the diameter</span></li>\r\n\t<li><span style=\"font-size:14px\">They are used alongwith a Manual Vacuum Aspiration (MVA) syringe to evacuate the products of conception (Suction and Evacuation) in the following scenarios</span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\">Surgical MTP &lt; 12 weeks</span></li>\r\n\t\t<li><span style=\"font-size:14px\">Incomplete abortion</span></li>\r\n\t\t<li><span style=\"font-size:14px\">Inevitable abortion</span></li>\r\n\t\t<li>Molar pregnancy</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><em><strong>Option A: Uterine curette appears as shown:&nbsp;</strong></em></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/16/image-20231216100447-1.png\" style=\"height:183px; width:275px\" /></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Option C: MVA syringe: This is the apparatus in which the vacuum is created manually and the priducts of conception collect in the syringe (60 ml)</strong></span></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/16/image-20231216100544-2.jpeg\" style=\"height:225px; width:225px\" /></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option D: Pipelle biopsy cannula: This is a very thin disposable cannula used to take an office endometrial biopsy in women with AUB</strong></em></span></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/16/image-20231216100644-3.jpeg\" style=\"height:215px; width:235px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\">It is a plastic disposable cannula which ic color coded (based on the diameter)</span></li>\r\n\t<li><span style=\"font-size:14px\">It is used with the Manual Vacuum Aspiration (MVA) syringe to evacuate products of conception in</span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\">Surgical MTP &lt; 12 weks</span></li>\r\n\t\t<li><span style=\"font-size:14px\">Incomplete abortion</span></li>\r\n\t\t<li><span style=\"font-size:14px\">Inevitable abortion</span></li>\r\n\t\t<li><span style=\"font-size:14px\">Molar pregnancy</span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Berek and Novak, 16<sup>th</sup> edition, page 2770 </span></span></strong></span></span></span></p>",
    "correct_choice_id": 76393,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 19110,
    "choices": [
      {
        "id": 76400,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">No further follow up required</span></span></span></p>"
      },
      {
        "id": 76401,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Till One more negative value 1 month later</span></span></span></p>"
      },
      {
        "id": 76402,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monthly follow up for 6 months </span></span></span></p>"
      },
      {
        "id": 76403,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monthly follow up for 1 year</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman underwent suction evacuation for complete mole. She was on weekly hCG follow up which has now returned to normal. What will be your advise to her for further follow up: </span></span></p>",
    "unique_key": "Q4948097",
    "question_audio": null,
    "question_video": null,
    "map_id": 31054,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Monthly follow up for 6 months</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"color:#1c1d1e; font-family:Calibri,sans-serif\"><span style=\"font-size:16px\">Following evacuation of molar pregnancy, there is a risk of progression to choriocarcinoma and hence surveillance is done by checking the beta hCG levels.&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><em><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Coming Soon&quot;\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Post Evacuation Surveillance of molar pregnancy</span></span></span></span></span></strong></em></li>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Risk of progression to GTN is higher following complete mole (15%) than partial mole (5%)</span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Surveillance is done by&nbsp;</span></span>serial measurement of&nbsp;<span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EL\">&beta;</span> hCG to detect persistent/ renewed trophoblastic proliferation.</span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">The initial baseline value is taken 2 days post evacuation&nbsp;</span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Then weekly&nbsp; beta hCGS are done till negative (This ususlaly takes 7 weeks for partial mole; 9 weeks for complete mole) </span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Once beta hCG is negative on weekly measurements, it is measured monthly for 6 months&nbsp;</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<h1><em><strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Educational Objective:&nbsp;</span></span></strong></em></h1>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><em><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Coming Soon&quot;\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Post Evacuation Surveillance of molar pregnancy</span></span></span></span></span></strong></em></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Risk of progression to GTN is higher following complete mole (15%) than partial mole (5%)</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Surveillance is done by&nbsp;</span></span>serial measurement of&nbsp;<span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">&beta; hCG to detect persistent/ renewed trophoblastic proliferation.</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">The initial baseline value is taken 2 days post evacuation&nbsp;</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Then weekly&nbsp; beta hCGS are done till negative (This ususlaly takes 7 weeks for partial mole; 9 weeks for complete mole) </span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Once beta hCG is negative on weekly measurements, it is measured monthly for 6 months&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h1><strong><span style=\"font-size:24pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: FIGO cancer report, 2021</span></span></span></span></strong></h1>",
    "correct_choice_id": 76402,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 19111,
    "choices": [
      {
        "id": 76404,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">No further follow up required</span></span></span></span></span></p>"
      },
      {
        "id": 76405,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">One more follow up 1 month later (if negative stop follow up)</span></span></span></span></span></p>"
      },
      {
        "id": 76406,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Monthly follow up for 6 months, from date of evacuation</span></span></span></span></span></p>"
      },
      {
        "id": 76407,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Monthly follow up for 6 months, from date of normalization </span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A woman underwent suction evacuation and histopathology shows complete mole. She was kept on weekly hCG follow up. Her hCG returned to normal in 6 weeks. What is further plan for follow up:</span></span></span></p>",
    "unique_key": "Q7425918",
    "question_audio": null,
    "question_video": null,
    "map_id": 31055,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D . Monthly follow up for 6 months, from date of normalization</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li>ollowing evacuation of molar pregnancy, there is a risk of progression to choriocarcinoma and hence surveillance is done by checking the beta hCG levels.&nbsp;</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><em><strong>Post Evacuation Surveillance of molar pregnancy</strong></em></li>\r\n\t<li>\r\n\t<ul>\r\n\t\t<li>Risk of progression to GTN is higher following complete mole (15%) than partial mole (5%)</li>\r\n\t\t<li>Surveillance is done by&nbsp;serial measurement of&nbsp;&beta; hCG to detect persistent/ renewed trophoblastic proliferation.</li>\r\n\t\t<li>The initial baseline value is taken 2 days post evacuation&nbsp;</li>\r\n\t\t<li>Then weekly&nbsp; beta hCGS are done till negative (This ususlaly takes 7 weeks for partial mole; 9 weeks for complete mole)</li>\r\n\t\t<li>Once beta hCG is negative on weekly measurements, it is measured monthly for 6 months&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<h1><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></h1>\r\n\r\n<ul>\r\n\t<li><em><strong>Post Evacuation Surveillance of molar pregnancy</strong></em>\r\n\r\n\t<ul>\r\n\t\t<li>Risk of progression to GTN is higher following complete mole (15%) than partial mole (5%)</li>\r\n\t\t<li>Surveillance is done by&nbsp;serial measurement of&nbsp;&beta; hCG to detect persistent/ renewed trophoblastic proliferation.</li>\r\n\t\t<li>The initial baseline value is taken 2 days post evacuation&nbsp;</li>\r\n\t\t<li>Then weekly&nbsp; beta hCGS are done till negative (This ususlaly takes 7 weeks for partial mole; 9 weeks for complete mole)</li>\r\n\t\t<li>Once beta hCG is negative on weekly measurements, it is measured monthly for 6 months&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<h1><span style=\"font-size:24pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: figo cancer report, 2021</span></span></strong></span></span></h1>",
    "correct_choice_id": 76407,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 19115,
    "choices": [
      {
        "id": 76420,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Gestational trophoblastic neoplasia</span></span></span></span></span></p>"
      },
      {
        "id": 76421,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Recurrence of molar pregnancy</span></span></span></span></span></p>"
      },
      {
        "id": 76422,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Relapse of Molar pregnancy</span></span></span></span></span></p>"
      },
      {
        "id": 76423,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Trophoblastic embolization</span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">A 30-year-old woman underwent suction evacuation for molar pregnancy. Her hCG surveillance is as follows. What is the probable cause: </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">1 March: 200</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">7 March: 120</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">14 March: 900</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">21 March: 1300</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">28 March: 1700</span></span></span></span></span></p>",
    "unique_key": "Q2631794",
    "question_audio": null,
    "question_video": null,
    "map_id": 31056,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ans. A. Gestational trophoblastic neoplasia</span></span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Box 1.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">FIGO criteria for diagnosis of postmolar gestational trophoblastic neoplasia</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/9_0E8e20u.jpg\" style=\"height:310px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option B and C: </strong>Recurrence of molar and relapse of molar: This is unlikely and would be called recurrence only if beta hCG touches normal and then she has another molar pregnancy</em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option D: Trophoblastic embolization: </strong>This is a rare complication which can happen during evacuation of molar pregnancy and the patient presents with sudden carsiorespiratory arrest</em></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:14px\"><em>Educational Objective:&nbsp;</em></span></strong></p>\r\n\r\n<ul>\r\n\t<li><strong><span style=\"font-size:14px\"><em>Gestational Trophoblastic Neoplasia should be suspected in a patient who has had a suction evacuation done followed by plateauing or increasing beta hCG levels OR of beta hCG persists even after 6 months of molar evacuation</em></span></strong></li>\r\n\t<li><span style=\"font-size:14px\"><strong><em>If the question says that the beta hCG came to zero and again became positive, in such a scenario the 1st thing to think of is pregnancy</em></strong></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ref: FIGO cnacer report 2021</span></span></span></strong></span></span></p>",
    "correct_choice_id": 76420,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 19119,
    "choices": [
      {
        "id": 76436,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">First trimester Abortion</span></span></span></span></span></p>"
      },
      {
        "id": 76437,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Molar pregnancy</span></span></span></span></span></p>"
      },
      {
        "id": 76438,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Term pregnancy&nbsp;</span></span></span></span></span></p>"
      },
      {
        "id": 76439,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">All of the above </span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GTN can occur after: </span></span></p>",
    "unique_key": "Q2506637",
    "question_audio": null,
    "question_video": null,
    "map_id": 31057,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D. </span></span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">All of the above </span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">Gestational Trophophoblastic neoplasia (GTN) is most commnly seen after evacuation of a molar pregnancy (complete mole &gt; partial mole). This accounts for about 50% of all GTN.&nbsp;</span></li>\r\n\t<li><span style=\"font-size:16px\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">As about 50% of GTN follows molar pregnancy, the rest can occur after a spontaneous abortion, ectopic pregnancy, or a term pregnancy.</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:Arial,Helvetica,sans-serif\">Educational Objective:&nbsp;</span></strong></em></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Gestational Trophoblastic Neoplasia can occur following Molar pregnancy (most commonly; complete mole &gt; partial mole) but can also happen after a term/ preterm pregnancy or after an abortion or an ectopic pregnancy</strong></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: FIGO cancer report 2021</span></strong></span></span></p>",
    "correct_choice_id": 76439,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 19126,
    "choices": [
      {
        "id": 76464,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">3 months</span></span></span></span></p>"
      },
      {
        "id": 76465,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">6 months</span></span></span></span></p>"
      },
      {
        "id": 76466,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">1 year</span></span></span></span></p>"
      },
      {
        "id": 76467,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">2 years</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">You have just completed the chemotherapy of GTN patient. How long will you ask her to follow up: </span></span></span></p>",
    "unique_key": "Q6816129",
    "question_audio": null,
    "question_video": null,
    "map_id": 31060,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. 1 year</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">After treatment of a GTN, follow-up hCG monitoring every month for at least 12&nbsp;months is essential for surveillance of relapse. Reliable contraception must be used throughout this period.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Future fertility, pregnancy, and offspring are not affected, although psychosocial and sexual counseling may be needed for some patients.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: figo cancer report 2021</span></strong></span></span></p>",
    "correct_choice_id": 76466,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 18973,
    "choices": [
      {
        "id": 75852,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Melanoma</span></span></span></p>"
      },
      {
        "id": 75853,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Basal cell carcinoma</span></span></span></p>"
      },
      {
        "id": 75854,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Squamous cell carcinoma</span></span></span></p>"
      },
      {
        "id": 75855,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bartholin gland adenocarcinoma</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72y old woman who preseted with a lesion on the vulva underwent a biopsy. This was diagnosed as squamois cell carcinoma which is the most common pathology in vulvar cancers. Which of the following is the second most common vulvar malignancy and accounts for up to 10 percent of all vulvar cancers?</span></span></p>",
    "unique_key": "Q2730441",
    "question_audio": null,
    "question_video": null,
    "map_id": 31066,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. Melanoma</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Of vulvar tumors, approximately 90 percent are squamous cell carcinoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malignant melanoma is the second most common, but rare histologic subtypes may also be encountered. </span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The etiology of vulval cancer is unclear but certain high risk factors are known to be associated</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Postmenopausal women; median age about 60 years</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">White race</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Obesity, Hypertension and Diabetes are known associations</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">More common in nulliparous women</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lichen sclerosis</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HPV (esp high risk types - 16,18)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic vulvar irritation</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Premalignant lesions - vulvar intra-epithelial neoplasia</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 707, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75852,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 18975,
    "choices": [
      {
        "id": 75860,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lichen planus</span></span></span></p>"
      },
      {
        "id": 75861,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tobacco abuse </span></span></span></p>"
      },
      {
        "id": 75862,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lichen sclerosus </span></span></span></p>"
      },
      {
        "id": 75863,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Human papillomavirus</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 65y postmenopausal woman is dignosed with vulval cancer. She is very surprised as she has been having a very healthy lifestyle. She asks you the risk factors for vulval cancer. Which of the following is not a risk factor for vulval cancer? </span></span></span></p>",
    "unique_key": "Q7622405",
    "question_audio": null,
    "question_video": null,
    "map_id": 31068,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A Lichen planus</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Risk factors of vulvar cancer are</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">More common in older age (&gt; 60y) and white race</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased association with obesity, HTN, diabetes and nulliparoty</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget&#39;s disease, squamous cell hyperplasia, condyloma acuminata</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HPV (high risk type 16, 18)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic pruritis, chronic irritation of the vulva</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vulvar intra-epithepithelial lesion</span></span></span>&nbsp;(VIN)</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Lichen planus</strong> may affect the skin anywhere on the body. It affects the mucosal surfaces (oral mucosa) and presents with polygenal flat-topped purpuric plaques. The lesion may be erosive and presents more with pain than pruritus. It is NOT commonly associated with vulvar carcinoma</p>\r\n\r\n<p><strong>Educational Objective:</strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Risk factors of vulvar cancer are</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">More common in older age (&gt; 60y) and white race</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased association with obesity, HTN, diabetes and nulliparoty</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget&#39;s disease, squamous cell hyperplasia, condyloma acuminata</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HPV (high risk type 16, 18)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic pruritis, chronic irritation of the vulva</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vulvar intra-epithepithelial lesion</span></span></span>&nbsp;(VIN)</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 708, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75860,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 18979,
    "choices": [
      {
        "id": 75876,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Biopsy the lesion in your office</span></span></span></p>"
      },
      {
        "id": 75877,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prescribe estrogen cream and follow up in 3 months</span></span></span></p>"
      },
      {
        "id": 75878,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Perform a wide local excision in the operating room</span></span></span></p>"
      },
      {
        "id": 75879,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prescribe clobetasol</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old woman presents for her annual well woman examination and complains of vulvar pruritis. During examination, you note an area of thickened white plaque. What is the most appropriate next step? </span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-740.jpg\" style=\"height:294px; width:400px\" /></span></span></p>",
    "unique_key": "Q5380357",
    "question_audio": null,
    "question_video": null,
    "map_id": 31071,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Biopsy the lesion in your office</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><em>A post-menopausal woman with a vulvar lesion should be biopsied to rule out vulvar malignancy.&nbsp;</em></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lesions may be raised, ulcerated, pigmented, or warty</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Importantly, other clinical entities may present similarly and include preinvasive neoplasia (VIN), infection, chronic inflammatory disease, and granulomatous disease, so a biopsy should be done.&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multiple biopsies are recommended, from the most suspicious raised or dyspigmented skin are taken</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Concurrent colposcopic examination of the cervix and vagina and careful evaluation of the perianal area are recommended to diagnose any synchronous lesions or associated neoplasm of the lower genital tract</span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong>Other options</strong></em></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\">Clobetasol is a local steroid which may help in several skin conditions but a biopsy is important before prescribing medication</li>\r\n\t<li style=\"text-align:justify\">Estrogen cream is prescribed for vaginal/ vulvar dryness/ dyspareunia in post menopausal women (Hormone replacement therapy). However the above image does not appear to be a menopausal related vulvar lesion</li>\r\n\t<li style=\"text-align:justify\">Once biopsy shows a vulvar malignancy, then further evaluation is done to stage the tumor (clinical staging). For microscopic lesions, a wide local excision can be done</li>\r\n</ul>\r\n\r\n<p><em><strong>Educational Objective:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><em>A post-menopausal woman with a vulvar lesion should be biopsied to rule out vulvar malignancy.&nbsp;</em></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lesions may be raised, ulcerated, pigmented, or warty</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Importantly, other clinical entities may present similarly and include preinvasive neoplasia (VIN), infection, chronic inflammatory disease, and granulomatous disease, so a biopsy should be done.&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multiple biopsies are recommended, from the most suspicious raised or dyspigmented skin are taken</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Concurrent colposcopic examination of the cervix and vagina and careful evaluation of the perianal area are recommended to diagnose any synchronous lesions or associated neoplasm of the lower genital tract</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 708, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75876,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 18988,
    "choices": [
      {
        "id": 75912,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Grade </span></span></span></p>"
      },
      {
        "id": 75913,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumor size </span></span></span></p>"
      },
      {
        "id": 75914,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Depth of invasion </span></span></span></p>"
      },
      {
        "id": 75915,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymph node metastasis </span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56y woman is diagnosed to have a stage 2 vulvar carcinoma and she undergoes a radical vulvectomy. What is the most important prognostic factor in vulvar cancer? </span></span></p>",
    "unique_key": "Q7312482",
    "question_audio": null,
    "question_video": null,
    "map_id": 31076,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D.</span> </strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymph node metastasis</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prognostic factors in vulval ca are:</span></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymph node metastases<strong> (This is the single most important vulvar cancer predictor, since inguinal node metastasis reduces long-term survival rates by 50 percent)</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FIGO Stage</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lesion size</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Depth of invasion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Resected-margin status and </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphatic vascular space involvement (LVSI)</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 710, Williams Gyn, 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75915,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 18992,
    "choices": [
      {
        "id": 75928,
        "text": "<p><span style=\"font-size:12.0pt;\">Spare the saphenous vein</span></p>"
      },
      {
        "id": 75929,
        "text": "<p><span style=\"font-size:12.0pt;\">Use compression stockings</span></p>"
      },
      {
        "id": 75930,
        "text": "<p><span style=\"font-size:12.0pt;\">Transpose the sartorius muscle</span></p>"
      },
      {
        "id": 75931,
        "text": "<p><span style=\"font-size:12.0pt;\">Avoid drain placement at the time of inguinofemoral dissection</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">What technique can decrease the risk of lymphedema in inguinofemoral lymphadenectomy ?</span></p>",
    "unique_key": "Q5579211",
    "question_audio": null,
    "question_video": null,
    "map_id": 31079,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A. Spare the saphenous vein.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Explanation</span></p><p>&nbsp;</p><ul><li><span style=\"background-color:transparent;font-size:16px;\">Chronic lymphedema is a well-known complication following inguinofemoral lymphadenectomy, particularly in the management of vulvar cancer.</span></li><li><span style=\"font-size:16px;\">Preservation o the saphenous vein has been shown to reduce the incidence</span></li><li><span style=\"font-size:16px;\">Regardless, this condition is typically much more problematic with the addition of groin radiation</span></li><li><span style=\"font-size:16px;\">Supportive management is meant to minimize the edema and prevent symptomatic progression.</span></li><li><span style=\"font-size:16px;\">Foot elevation, compression stockings, and, on occasion, diuretic therapy may be helpful</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: !245, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
    "correct_choice_id": 75928,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 19004,
    "choices": [
      {
        "id": 75976,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is typically a disease of the elderly</span></span></span></p>"
      },
      {
        "id": 75977,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It commonly arises from the labia minora and clitoris</span></span></span></p>"
      },
      {
        "id": 75978,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Differential diagnoses include seborrheic keratosis and dysplastic nevi</span></span></span></p>"
      },
      {
        "id": 75979,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is more common in African American women than Caucasian women</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is INCORRECT regarding the tumor shown here involving the outer surface of the right labia minora?</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-743.jpg\" style=\"height:410px; width:400px\" /></span></span></p>",
    "unique_key": "Q6165037",
    "question_audio": null,
    "question_video": null,
    "map_id": 31086,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D. It is more common in African American women than Caucasian women.</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a vulvar carcinoma which&nbsp;appears like a melanoma as It is pigmented</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Let us discuss all the options:&nbsp;</span></span></span>\r\n\t<ul>\r\n\t\t<li><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A: It is typically a disease of the elderly: </span></span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is correct. Vulvla melanoma disproprtionately affects the elderly&nbsp;</span></span></span></li>\r\n\t\t<li><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B: It commonly arises from the labia minora and clitoris. </span></span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is also correct. The common sites are the laboa minora, majora and clitoris</span></span></span></li>\r\n\t\t<li><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C: Differential diagnoses include seborrheic keratosis and dysplastic nevi. </span></span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is also correct</span></span></span><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.&nbsp;</span></span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diferential diagnosis include pigmented lesions like&nbsp;include lentigo simplex, vulvar melanosis, acanthosis nigricans, seborrheic keratosis, and nevi</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. It is more common in African American women than Caucasian women: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is incorrect. It is more common amongst whites.&nbsp;</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vulval melanoma is the second most common vulvar cancer and accounts or 10 percent of all vulvar malignancies. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vulvar melanoma disproportionately affects the elderly and develops more commonly among whites than other races. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vulvar melanoma has an overall poor prognosis, and 5-year survival rates range from 8 to 55 percent </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malignant vulvar melanomas most commonly arise from the labia minora, labia majora, or clitoris </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Some benign pigmented lesions can also be found here and include lentigo simplex, vulvar melanosis, acanthosis nigricans, seborrheic keratosis, and nevi </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tissue sampling is mandatory for diagnosis</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 716, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75979,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 18981,
    "choices": [
      {
        "id": 75884,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 mm </span></span></span></p>"
      },
      {
        "id": 75885,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3 mm </span></span></span></p>"
      },
      {
        "id": 75886,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5 mm </span></span></span></p>"
      },
      {
        "id": 75887,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">7 mm </span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the maximum depth of invasion to be considered minimally invasive vulvar cancer?</span></span></p>",
    "unique_key": "Q5910416",
    "question_audio": null,
    "question_video": null,
    "map_id": 31072,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. 1 mm</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Minimally invasive vulvar cancer is Stage 1a1 where the depth of invasion is &lt; 1mm</span></span></span></strong></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/screenshot-2023-09-02-151851_xfx5lfx.jpg\" style=\"height:785px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-742.jpg\" style=\"height:859px; width:600px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>&nbsp;</li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 682, Williams Gynecology, 3rd edition</span></span></span></strong></p>",
    "correct_choice_id": 75884,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 18974,
    "choices": [
      {
        "id": 75856,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Femoral artery </span></span></span></p>"
      },
      {
        "id": 75857,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">External iliac artery </span></span></span></p>"
      },
      {
        "id": 75858,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Internal iliac artery </span></span></span></p>"
      },
      {
        "id": 75859,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Superficial pudendal artery</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The internal pudendal artery is a branch of which artery? </span></span></p>",
    "unique_key": "Q9624358",
    "question_audio": null,
    "question_video": null,
    "map_id": 31067,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: C. Internal iliac artery</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The internal pudendal artery is a branch of the internal iliac artery</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-739.jpg\" style=\"height:413px; width:800px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 705, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75858,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 19323,
    "choices": [
      {
        "id": 77252,
        "text": "<p><span style=\"background-color:transparent;font-size:16px;\">Ultrasonography&nbsp;</span></p>"
      },
      {
        "id": 77253,
        "text": "<p><span style=\"color:#46403d;font-size:12pt;\">CT scan</span></p>"
      },
      {
        "id": 77254,
        "text": "<p><span style=\"color:#46403d;font-size:12.0pt;\">MRI</span></p>"
      },
      {
        "id": 77255,
        "text": "<p><span style=\"color:#46403d;font-size:12pt;\">All of the above</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 55 years old P5L5 presented to OPD with postcoital bleeding and vaginal discharge. On examination, there is a 3 x 3cm growth involving the entire cervix. The growth does not seem to extend to the vagina and the parametrium is free. Which of the following investigations can be used for staging of cancer cervix:</span></p>",
    "unique_key": "Q8081033",
    "question_audio": null,
    "question_video": null,
    "map_id": 31089,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. All of the above</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">In 2018, the FIGO (Federation of International Gynecologists and Obstetricians) Gynecologic Oncology Committee revised the staging to allow the option of clinical, radiological, or pathological findings, as available, to assign the stage. FIGO 2018 staging permits the use of any of the imaging modalities according to available resources,<strong> i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)</strong>, to provide additional information on tumor size, nodal status, and local or systemic spread.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">MRI is the best method of radiologic assessment of primary tumors greater than 10&nbsp;mm.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">T<strong>he stage is allocated after all imaging and pathology reports are available</strong>. It is not to be altered later, for example at recurrence.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">Educational Objective:</span></p><p>&nbsp;</p><ul><li><p style=\"text-align:justify;\">Cervical cancer is primarily a clinical staging but F<span style=\"background-color:white;font-size:12pt;\">IGO 2018 staging permits the use of any of the imaging modalities according to available resources,<strong> i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)</strong>, to provide additional information on tumor size, nodal status, and local or systemic spread.</span></p></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref&nbsp; : FIGO cancer report 2021</strong></span></p>",
    "correct_choice_id": 77255,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 19328,
    "choices": [
      {
        "id": 77272,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB1</span></span></span></p>"
      },
      {
        "id": 77273,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB2</span></span></span></p>"
      },
      {
        "id": 77274,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB3</span></span></span></p>"
      },
      {
        "id": 77275,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IIA1</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 57 year old woman presents to OPD with complaint of discharge per vagina. There is a 3*3 cm visible growth on the cervix. Vagina and parametrium are uninvolved. The stage of the disease is: </span></span></p>",
    "unique_key": "Q7496682",
    "question_audio": null,
    "question_video": null,
    "map_id": 31064,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Stage IB2</span></strong></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901123.jpg\" style=\"height:1770px; width:1000px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>In this patient, the cancer is limited to the cervix and between 2 cm to 4 cm so this is 1B2</strong></li>\r\n</ul>\r\n\r\n<p><strong>Educational Objective:</strong></p>\r\n\r\n<p><strong>Staging of cervical cancr is essential to learn as given in the table above</strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref :&nbsp; FIGO cancer report 2021</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>",
    "correct_choice_id": 77273,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 19333,
    "choices": [
      {
        "id": 77292,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Stage IIA1</span></span></span></span></p>"
      },
      {
        "id": 77293,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Stage IIA2</span></span></span></p>"
      },
      {
        "id": 77294,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Stage IIBr</span></span></span></p>"
      },
      {
        "id": 77295,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Stage IIIB2r</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 50 years lady presents with foul smelling vaginal discharge since a few months. She is post-menopausal since 2 years. On examination, there is a 3.5 x 3cm growth, involving the upper part of vagina and bilateral parametrium appears free. An MRI done, shows growth involving upper vagina and parametrium, but not upto the lateral pelvic wall. The stage of the disease is:</span></span></span></p>",
    "unique_key": "Q7828206",
    "question_audio": null,
    "question_video": null,
    "map_id": 31065,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: C: Stage IIBr</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">FIGO CANCER REPORT 2021</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Staging of cancer cervix:&nbsp;</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical cancer is a clinical staging but certain investigations and pathology can be used to aid in staging.&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per the recent FIGO staging (20021), this is Stage II B r</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&#39;r&#39; refers to findings on &#39;radiology&#39;</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong>Staging of Cervical cancer (FIGO 2021)</strong></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901123.jpg\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14px\">Educational Objectve:&nbsp;</span></strong></p>\r\n\r\n<p><strong><span style=\"font-size:14px\">Cervical cancer staging is primarily a clinical staging and it it svery important to know the staging as shown in the table above</span></strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and novak 16<sup>th</sup> edition, 2455</span></strong></span></span></p>",
    "correct_choice_id": 77294,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 18983,
    "choices": [
      {
        "id": 75892,
        "text": "<p>I</p>"
      },
      {
        "id": 75893,
        "text": "<p>II</p>"
      },
      {
        "id": 75894,
        "text": "<p>III</p>"
      },
      {
        "id": 75895,
        "text": "<p>IVA</p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A gynecological oncologist performs a radical vulvectomy and bilateral inguinofemoral lymph node dissection for a 3-cm invasive squamous cell carcinoma of the vulva involving the lower third of the vagina. The final histo-pathologic analysis of the specimen reveals margins and lymph nodes that are negative for cancer. Based on these findings, which International Federation of Gynecology and Obstetrics (FIGO) stage is she assigned?</span></span></p>",
    "unique_key": "Q8200397",
    "question_audio": null,
    "question_video": null,
    "map_id": 31073,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: B. II</span></strong></span></span></p>\r\n\r\n<p>As per the FIGO staging, the patient is Stage II</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/screenshot-2023-09-02-151851.jpg\" style=\"height:785px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-742_VdLVY3u.jpg\" style=\"height:859px; width:600px\" /></span></span></span></p>",
    "correct_choice_id": 75893,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 18997,
    "choices": [
      {
        "id": 75948,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemoradiation </span></span></span></p>"
      },
      {
        "id": 75949,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pelvic exenteration </span></span></span></p>"
      },
      {
        "id": 75950,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemoradiation followed by radical vulvectomy </span></span></span></p>"
      },
      {
        "id": 75951,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radical vulvectomy with bilateral inguinofemoral lymph node dissection</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most appropriate treatment for a 55-yearold patient with a 4-cm squamous cell carcinoma of the vulva involving the urethral meatus and a medical history significant for systemic lupus erythematosus? </span></span></p>",
    "unique_key": "Q1115546",
    "question_audio": null,
    "question_video": null,
    "map_id": 31084,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D. Radical vulvectomy with bilateral inguinofemoral lymph node dissection</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This patient is stage 3 vulvar cancer.&nbsp;</span></span></span></li>\r\n\t<li>The management of stage 3 vulcar cancer is modified radical vulvectomy with b/l inguinofemoral lymphadenectomy</li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of vulval cancer</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:black\">For both <strong>stage I and stage 2</strong> disease: radical local excision and sentinel node dissection is indicated, and groin dissection is reserved for those with metastasis to the sentinel node(s).</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">For stage 3:</span></span></strong></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Modified radical or radical vulvectomy with inguinal and femoral lymphadenectomy is the standard therapy.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Nodal involvement is a key determinant of survival. Radiation therapy is given to patients with large primary lesions and narrow margins. </span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Stage 4: </span></span></strong></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Radical vulvectomy and pelvic exenteration may be indicated for patients with stage IVA vulvar cancer.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Surgery followed by radiation therapy may be done for large, resected lesions with narrow margins.</span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This patient has a stage 2 or 3 vulvar carcinoma (As lymph nodal status is not mentioned); and the best treatment option is a radical vulvectomy with b/l LN inguino-femoral dissection</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Her medical history wil not change her treatment</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 714, Williams Gynecology 3<sup>rd</sup> edition</span></span></strong></span></span></span></p>",
    "correct_choice_id": 75951,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 19005,
    "choices": [
      {
        "id": 75980,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wide local excision with a 1-cm margin </span></span></span></p>"
      },
      {
        "id": 75981,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wide local excision with a 2-cm margin </span></span></span></p>"
      },
      {
        "id": 75982,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radical vulvectomy with right inguinofemoral lymph node dissection </span></span></span></p>"
      },
      {
        "id": 75983,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radical vulvectomy with bilateral inguinofemoral lymph node dissection</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is the most appropriate treatment for a 3-cm basal cell carcinoma of the right vulva, 2cm from the midline? </span></span></span></p>",
    "unique_key": "Q6497500",
    "question_audio": null,
    "question_video": null,
    "map_id": 31087,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. Wide local excision with a 1-cm margin</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a basal cell carcinoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Basal cell carcinoma (BCC) of the vulva accounts or &lt; 2 percent of all vulvar cancers and is most commonly found in elderly women </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lesions typically arise on the labia majora, are characterized by poor pigmentation and pruritus, and often mimic eczema, psoriasis, or intertrigo. . </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Basal cell carcinoma is removed by radical partial vulvectomy using a minimum surgical margin of 1 cm. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphatic or distant spread is rare, but inguino femoral lymphadenectomy or Sentniel lymoh node biopsy&nbsp;is considered on clinically suspicious nodes. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 717, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75980,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19113,
    "choices": [
      {
        "id": 76412,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Barrier methods</span></span></span></span></span></p>"
      },
      {
        "id": 76413,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Copper T</span></span></span></span></span></p>"
      },
      {
        "id": 76414,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Injection DMPA</span></span></span></span></span></p>"
      },
      {
        "id": 76415,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Oral contraceptive pills </span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are counselling a patient regarding management of molar pregnancy. Which of the following contraceptive is contraindicated in patients after evacuation for molar pregnancy:</span></span></p>",
    "unique_key": "Q6119312",
    "question_audio": null,
    "question_video": null,
    "map_id": 31074,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B. Copper T</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Patients are encouraged to use effective contraception during the entire interval of hCG follow-up. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Because of the potential risk of uterine perforation, bleeding, and infection, intrauterine devices should not be inserted until the patient achieves a normal hCG level. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">If the patient does not desire surgical sterilization, either oral contraceptives or barrier methods should be used.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option A: Barrier contraception:&nbsp;</strong></em>Barrier method of contraception is safe and can be used</span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option C:&nbsp;Inj DMPA:&nbsp;</strong></em> Injection DMPA can be used safely </span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option D: Combined oral contraceptive pills:&nbsp;</strong><span style=\"font-family:Arial,Helvetica,sans-serif\">Combined oral pills can be used after the hCG value has become normal</span></em></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong><em><span style=\"font-family:Arial,Helvetica,sans-serif\">Educational Objective:&nbsp;</span></em></strong></span></p>\r\n\r\n<ul>\r\n\t<li><em><strong><span style=\"font-size:14px\">Post molar evacuation, contraception is advised till the period of beta hCG surveillance</span></strong></em></li>\r\n\t<li><em><strong><span style=\"font-size:14px\">All contraceptives are safe except Intra-Uterine Devices.&nbsp;</span></strong></em></li>\r\n\t<li><em><strong><span style=\"font-size:14px\">Combined OCPs can be started after beta hCG values return to normal</span></strong></em></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: berek and novak, 16<sup>th</sup> edition, page 2772</span></span></strong></span></span></span></p>",
    "correct_choice_id": 76413,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 19114,
    "choices": [
      {
        "id": 76416,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choriocarcinoma</span></span></span></p>"
      },
      {
        "id": 76417,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Epithelioid trophoblastic tumor (ETT)</span></span></span></span></span></p>"
      },
      {
        "id": 76418,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molar pregnancy</span></span></span></p>"
      },
      {
        "id": 76419,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Placental site trophoblastic tumor (PSTT)</span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational trophoblastic neoplasia includes <strong>all Except</strong>:</span></span></p>",
    "unique_key": "Q9378548",
    "question_audio": null,
    "question_video": null,
    "map_id": 31075,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ans. C. Molar pregnancy </span></span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">&nbsp; &nbsp; &nbsp; &nbsp;Modified WHO Classification of GTD</span></span></span></strong></span></span></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/16/image.png\" style=\"height:301px; width:608px\" /></p>\r\n\r\n<p><em><strong><span style=\"color:#1c1d1e; font-family:Calibri, sans-serif\"><span style=\"font-size:16px\">Gestational Trophoblastic&nbsp; Neoplasias include the following:&nbsp;</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\">Invasive mole</span></li>\r\n\t<li><span style=\"font-size:14px\">Choriocarcinoma</span></li>\r\n\t<li><span style=\"font-size:14px\">Placental site trophoblatic tumor</span></li>\r\n\t<li><span style=\"font-size:14px\">Epitheloid trophoblastic tumor</span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\">Molar pregnancy (partial anc complete) aren&#39;t included under gestational trophoblastic neoplasias.&nbsp;</span></strong></em></p>\r\n\r\n<p><em><strong>Educational Objective:&nbsp;</strong></em></p>\r\n\r\n<p><em><strong><span style=\"color:#1c1d1e\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\">Gestational Trophoblastic&nbsp; Neoplasias include the following:&nbsp;</span></span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\">Invasive mole</span></li>\r\n\t<li><span style=\"font-size:14px\">Choriocarcinoma</span></li>\r\n\t<li><span style=\"font-size:14px\">Placental site trophoblatic tumor</span></li>\r\n\t<li><span style=\"font-size:14px\">Epitheloid trophoblastic tumor</span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ref: FIGO cancer report 2021</span></span></span></strong></span></span></p>",
    "correct_choice_id": 76418,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 19120,
    "choices": [
      {
        "id": 76440,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 1</span></span></span></p>"
      },
      {
        "id": 76441,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 2</span></span></span></p>"
      },
      {
        "id": 76442,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 3</span></span></span></p>"
      },
      {
        "id": 76443,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 4 </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman has been admitted after 3 increasing weekly hCG values, 2 months after molar evacuation. On examination, cervix, vagina is healthy, uterus is normal size. Her Hb is 10g%, chest X-ray is shown below. What stage of GTN does she have?</span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/10_INAODUi.jpg\" style=\"height:232px; width:300px\" /></span></span></p>",
    "unique_key": "Q2925310",
    "question_audio": null,
    "question_video": null,
    "map_id": 31078,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Stage 3</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">TABLE 1.</span></strong><strong>&nbsp;<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">FIGO staging and classification for gestational trophoblastic neoplasia (GTN) is as shown in the table</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">As the patient in the given scenario has typical canon ball lung metastases on the chest X-Ray, she is Stage 3.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">Also note that lung metastases in GTN signifies a good prognosis and is very responsive to single agent chemotherapy with MEthotrexate being the drug of choice.&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/11_5Br7LYv.jpg\" style=\"height:504px; width:1000px\" /></span></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Staging of GTN:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/11_5Br7LYv.jpg\" style=\"height:504px; width:1000px\" /></span></span></span></p>\r\n\r\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\"><strong>Ref: FIGO cancer report 2021, Berek &amp; novak, 16th ed page 2775</strong></span></span></p>",
    "correct_choice_id": 76442,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 19122,
    "choices": [
      {
        "id": 76448,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Actinomycin D injection 5-day regimen</span></span></span></p>"
      },
      {
        "id": 76449,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EMA-CO regimen </span></span></span></p>"
      },
      {
        "id": 76450,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate-folinic acid 8-day regimen</span></span></span></p>"
      },
      {
        "id": 76451,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old woman develops GTN&nbsp; 10 months after abortion. Her beta hCG value is 1,20,000 mIU/mL. The chest X ray shows metastasis. The appropriate treatment for her would be:</span></span></p>",
    "unique_key": "Q2334859",
    "question_audio": null,
    "question_video": null,
    "map_id": 31080,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. EMA-CO regimen </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">From the information we have, her WHO prognostic score (See table below) would be: </span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age: 22: Scor 0</span></span></span></li>\r\n\t\t<li><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous pregnancy: Abortion: Score: 1</span></span></span></li>\r\n\t\t<li><span style=\"font-size:16px\">Interval from index pregnancy: 8 months: Score: 2</span></li>\r\n\t\t<li><span style=\"font-size:16px\">hCG level: 120000: Score: 4</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Lung mets: Score 0</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Size of tumor: Not mentioned</span></li>\r\n\t\t<li><span style=\"font-size:16px\">No of mets: Not mentiones</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Previous chemotherapy: not mentioned</span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:16px\">Total score = 7 which is HIGH RISK (Score &gt; 6 is high risk)</span></li>\r\n\t<li><span style=\"font-size:16px\">High risk requires multi agent chemotherapy with EMACO&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span></p>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">World Health Organization scoring system based on prognostic factors modified as FIGO score</span></span></span></strong></em></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/12_A3tO6F5.jpg\" style=\"height:719px; width:900px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><em><strong><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">A risk score of 6 and below is classified as low risk and above 6 is considered high risk. </span></span></span></span></span></strong></em></li>\r\n\t<li><em><strong><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy </span></span></span></strong></em></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Other Options</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Option A:&nbsp;</strong></em>Actinomycin D injection 5-day regimen: Actinomycin D is not the drug of choice in GTN. Methotrexate is the drug of choice in low risk GTN</span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Option C: </strong></em>Methotrexate folinic acid 8 day regime: This is the preferred drug in low risk GTN. This patient has high risk GTN as her score is 7.&nbsp;</span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Option D:&nbsp; </strong></em>Hysterectomy: Hysterectomy is rarely done in GTN. Indications include excessive bleeding or uterine perforation. Rarely in chemoresistance, hysterectomy can be resorted to.&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">The WHO prognostic scoring system in GTN determines the type of chemotherapy</span></li>\r\n\t<li><span style=\"font-size:16px\">If the score is &le;&nbsp;6, the patient requires single agent (Methotrexate) chemotherpay. This is given as 4 doses (1mg/Kg) alternating with 4 doses of folinic acid (0.1mg/kg) every 2-3 weeks.&nbsp;</span></li>\r\n\t<li><span style=\"font-size:16px\">If the score &gt; 7 the patient requires multiagent chemotherapy (EMACO). This includes&nbsp;<span dir=\"ltr\" lang=\"EN-IN\">etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: FIGO cancer report 2021</span></strong></span></span></p>",
    "correct_choice_id": 76449,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 19123,
    "choices": [
      {
        "id": 76452,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EMA-CO regimen </span></span></span></p>"
      },
      {
        "id": 76453,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Embolisation of vaginal nodule</span></span></span></p>"
      },
      {
        "id": 76454,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate-folinic acid 8 day regimen</span></span></span></p>"
      },
      {
        "id": 76455,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year woman develops GTN, 6 months after molar evacuation. On speculum examination, there is a reddish blue nodule in vagina. Her hCG is 24,000mIU/mL. chest XRay is normal. Mhe most appropriate treatment for her is</span></span></p>",
    "unique_key": "Q7183202",
    "question_audio": null,
    "question_video": null,
    "map_id": 31081,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Methotrexate-folinic acid 8 day regimen</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">As per the WHO prognostic scoring for GTN (shown in the table below, her score is 3</span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:16px\">Age 22:0</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Post molar evacuation:&nbsp;&nbsp;0</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Interval: 6 months: 1</span></li>\r\n\t\t<li><span style=\"font-size:16px\">hCG 24000: 1</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Mets: 1</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Site of mets: vagina: 0</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Prev chemo: 0</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Size not provided</span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:16px\">Therefore single agent multidose chemotherapy (Methotrexate with folinic acd) is preferred&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/14.jpg\" style=\"height:700px; width:900px\" /></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">A risk score of 6 and below is classified as low risk and above 6 is considered high risk.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">First-line single agent chemotherapy regimens for low-risk gestational trophoblastic neoplasia include methorexate (alternating with folinic acid). 2nd line drug is Actinomycin D.&nbsp;</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/15.jpg\" style=\"height:430px; width:900px\" /></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Other Options:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Option A: EMA-CO:</strong> This is the regime of choice in high risk GTN (Score of 7 and above)</span></p>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Option B: Embolization of vaginal nodule:</strong>&nbsp;Vaginal metastases may bleed profusely and torrential bleeding can occur following biopsy of a lesion. To control the bleeding, plication, packing the vagina or performing a wide local excision. Angiographic embolization of the hypogastric arteries can also be done.&nbsp;</span></p>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Option D: Hysterectomy </strong>is not an option in vaginal metastases in GTN</span></p>\r\n\r\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><em><span style=\"font-size:16px\"><strong>Ref: FIGO Cancer Report 2021</strong></span></em></span></p>",
    "correct_choice_id": 76454,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 19124,
    "choices": [
      {
        "id": 76456,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 weekly chemotherapy, response monitored by CA 125</span></span></span></p>"
      },
      {
        "id": 76457,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 weekly chemotherapy, response monitored by CA 125</span></span></span></p>"
      },
      {
        "id": 76458,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 weekly chemotherapy, response monitored by hCG</span></span></span></p>"
      },
      {
        "id": 76459,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 weekly chemotherapy, response monitored by hCG</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year woman with stage 2 GTN is receiving methotrexate-based chemotherapy. How frequently is chemotherapy given and what marker is used to assess response to treatment?</span></span></p>",
    "unique_key": "Q8303905",
    "question_audio": null,
    "question_video": null,
    "map_id": 31082,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. 2 weekly chemotherapy, response monitored by Hcg</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">hCG is used as a marker to diagnose development of GTN, response to chemotherapy and occurance of relapse</span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">Both EMACO and Methotrexate are given 2 weekly</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><strong>Option A and B: </strong>Monitoring is not by Ca 125. Ca 125 is a marker for epithelial ovarrianc ancer but is also found to be raised in fibroid, endometriosis, pregnancy, PID and genital TB</span></li>\r\n\t<li><span style=\"font-size:16px\"><strong>Option D: </strong>Methotrexate is given 2 weekly as per the recent FIGO cancer report of 2021.&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:16px\">Educational Objective:&nbsp;</span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">hCG is used as a marker to diagnose development of GTN, response to chemotherapy and occurance of relapse</span></span></li>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">Both EMACO and Methotrexate are given 2 weekly</span></span></li>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">EMACO is given for high risk GTN</span></span></li>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">Methotrexate is given for low risk GTN</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: FIGO cancer report 2021, Berek and Novak 16th ed Page 2757</span></strong></span></span></p>",
    "correct_choice_id": 76458,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 19125,
    "choices": [
      {
        "id": 76460,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy is given for one cycle followed by hCG follow up </span></span></span></p>"
      },
      {
        "id": 76461,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy is given for 6 cycles followed by hCG follow up</span></span></span></p>"
      },
      {
        "id": 76462,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy is given till hCG undetectable followed by hCG follow up</span></span></span></p>"
      },
      {
        "id": 76463,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy is given till hCG undetectable followed by 2-3 consolidation cycles followed by hCG follow up</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regarding chemotherapy in GTN, which of the following is true?</span></span></p>",
    "unique_key": "Q6523055",
    "question_audio": null,
    "question_video": null,
    "map_id": 31083,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Chemotherapy is given till hCG undetectable followed by 2-3 consolidation cycles followed by hCG follow up</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Administration of single-agent chemotherapy (generally 8-day MTX-FA for low risk GTN) every 2 weeks until hCG is undetected and then three consolidation courses to reduce the risk of relapse is recommended </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Patients who require combination chemotherapy (EMACO for high risk GTN) must be treated intensively to attain remission. Combination chemotherapy should be given as often as toxicity permits until the patient achieves three consecutive normal hCG levels. After normal hCG levels are attained, at least three additional courses of chemotherapy are administered to reduce the risk of relapse.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"color:#000000; font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Educational Objective:&nbsp;</em></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"color:#000000; font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Chemotherapy for GTN (for low risk: Mtx-FA and high risk: EMA-CO), it is given 2 weekly till hCG levels are undetectable followed by 2-3 consolidation doses&nbsp;</em></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: berek &amp; novak 16 edition, page 2785, 2786</span></strong></span></span></p>",
    "correct_choice_id": 76463,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 18976,
    "choices": [
      {
        "id": 75864,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0 </span></span></span></p>"
      },
      {
        "id": 75865,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5 </span></span></span></p>"
      },
      {
        "id": 75866,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">30</span></span></span></p>"
      },
      {
        "id": 75867,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">50</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What percentage of vulvar cancers is positive for human papillomavirus (HPV)?</span></span></p>",
    "unique_key": "Q4561529",
    "question_audio": null,
    "question_video": null,
    "map_id": 31069,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. 50</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p>Risk factors of vulvar cancer are</p>\r\n\r\n<ul>\r\n\t<li>More common in older age (&gt; 60y) and white race</li>\r\n\t<li>Increased association with obesity, HTN, diabetes and nulliparoty</li>\r\n\t<li>Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget&#39;s disease, squamous cell hyperplasia, condyloma acuminata</li>\r\n\t<li>HPV (high risk type 16, 18): in 50% of cases. A history of HPV genital warts have a 35-fold increased risk for developing vulvar cancer compared with women who have never developed these lesions.&nbsp;</li>\r\n\t<li>Chronic pruritis, chronic irritation of the vulva</li>\r\n\t<li>Vulvar intra-epithepithelial lesion&nbsp;(VIN)</li>\r\n</ul>\r\n\r\n<p><strong>Educational Objective:</strong></p>\r\n\r\n<p>HPV (high risk type 16, 18): is seen in 50% of cases of vulvar cancer.&nbsp; A history of HPV genital warts have a 35-fold increased risk for developing vulvar cancer compared with women who have never developed these lesions.</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 708, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75867,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 18990,
    "choices": [
      {
        "id": 75920,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphocele</span></span></span></p>"
      },
      {
        "id": 75921,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphedema </span></span></span></p>"
      },
      {
        "id": 75922,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Groin infection</span></span></span></p>"
      },
      {
        "id": 75923,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wound dehiscence </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 64y lady undergoes radical vulvectomy with inguinofermoral lymoh node dissection for vulvar cancer. What is the most common complication of an inguinofemoral lymph node dissection? </span></span></span></p>",
    "unique_key": "Q7083985",
    "question_audio": null,
    "question_video": null,
    "map_id": 31077,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: B. Lymphedema</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Following inguino-femoral lymph node dissection, the following complications are noted:&nbsp;</span></span></span></p>\r\n\r\n<ol>\r\n\t<li>Lymphedema:&nbsp;<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amongst all complications, the most common complication of inguino-femoral LN dissection is a lymohedema</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphocele</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Groin infection</span></span></span></li>\r\n\t<li>Groin necrosis</li>\r\n\t<li>Groin seperation</li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 715, Williams Gynecology, 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75921,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 18993,
    "choices": [
      {
        "id": 75932,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radiation alone</span></span></span></p>"
      },
      {
        "id": 75933,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemoradiation</span></span></span></p>"
      },
      {
        "id": 75934,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Close observation </span></span></span></p>"
      },
      {
        "id": 75935,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pelvic lymph node dissection </span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You perform a radical vulvectomy with bilateral inguinofemoral lymphadenectomy on a woman with a 4-cm squamous cell carcinoma tumor of the vulva. Margins are negative for cancer, but there are three positive lymph nodes. What is the most appropriate treatment?</span></span></p>",
    "unique_key": "Q7268729",
    "question_audio": null,
    "question_video": null,
    "map_id": 31085,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: B. Chemoradiation</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a stage III vulvar cancers (Tumor of any size with or without extension to adjacent perineal structures (lower 1/3rd urethera, lower 1/3rd vagina, anus) with positive inguino-femoral nodes.&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Women with stage III vulvar cancer are treated with surger followed by adjuvant radiation therapy directed to both groins and the pelvis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The addition of platinum-based chemotherapy concurrent with radiation therapy is also now given, and hence the best answer here is chemo-radiation</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 714, Williams Gyn, 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75933,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 19009,
    "choices": [
      {
        "id": 75996,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibiotics </span></span></span></p>"
      },
      {
        "id": 75997,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incision and drainage with marsupialization &nbsp;</span></span></span></p>"
      },
      {
        "id": 75998,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incision and drainage with excision of the gland</span></span></span></p>"
      },
      {
        "id": 75999,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incision and drainage</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 54-year-old woman presents with the persistent vulvar mass seen in the picture below and complaints of dyspareunia.&nbsp; What is the most appropriate management?</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-744.jpg\" style=\"height:270px; width:400px\" /></span></span></p>",
    "unique_key": "Q7702582",
    "question_audio": null,
    "question_video": null,
    "map_id": 31088,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: C.</span> </strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incision and drainage with excision of the gland</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a Bartholin gland cyst</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bartholin gland enlargement in a woman older than 40 years and recurrent cysts or abscesses warrants a biopsy or excision as there could be an underlying adenocarcinoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In a young woman, the treatment of choice of a Bartholin duct cyst is marsupialiation</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 718, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 75998,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 30882,
    "choices": [
      {
        "id": 123406,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SLNB is usually not recommended in vulvar carcinoma as lymphatic spread is rare</span></span></span></p>"
      },
      {
        "id": 123407,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SLNB is primarily used for staging and does not influence the management of vulvar carcinoma</span></span></span></p>"
      },
      {
        "id": 123408,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SLNB is used to identify the 1<sup>st</sup> lymph node(s) that cancer cells are likely to spread to and can guide lymph node dissection if positive</span></span></span></p>"
      },
      {
        "id": 123409,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SLNB is the sole definitive treatment for vulvar carcinoma and eliminates the need for further surgery or radiotherapy</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;A 52-year-old woman presents with a suspicious vulvar lesion. A biopsy confirms the presence of squamous cell carcinoma of the vulva. Clinical exam and imaging show no evidence of metastases. Her healthcare team decided to perform a sentinel lymph node biopsy (SLNB) to assess lymph node involvement. Which of the following is a true statement?</span></span></span></p>",
    "unique_key": "Q8398497",
    "question_audio": null,
    "question_video": null,
    "map_id": 31070,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: C. SLNB is used to identify the 1<sup>st</sup> lymph node(s) that cancer cells are likely to spread to and can guide lymph node dissection if positive</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Role of Sentinel LN Biopsy in Vulvar Carcinoma</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduces the requirement of LN dissection in vulvar carcinoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The main route of spread of vulvar carcinoma is lymphatic spread</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Done by lymphoscintigraphy with Tc99 labelled isosulfan blue dye/ indocyanine fluorescent green</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Groin incision made 10 mins later</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colored node is excised and examined</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If negative: No lymphadenectomy needs to be done</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If positive: B/l inguinofemoral lymphadenectomy is done</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> SLNB is usually not recommended in vulvar carcinoma as lymphatic spread is rare: This is a wrong statement as lymphatic spread is the most common route of spread of vulvar cancers</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> SLNB is primarily used for staging and does not influence the management of vulvar carcinoma: This is a wrong statement as SLNB is mainly done to reduce the risk of LN dissection thereby preventing complications</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> SLNB is the sole definitive treatment for vulvar carcinoma and eliminates the need for further surgery or radiotherapy: This is a wrong statement as SLNB is not the mainstay of treatment. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Role of Sentinel LN Biopsy in Vulvar Carcinoma</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduces the requirement of LN dissection in vulvar carcinoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The main route of spread of vulvar carcinoma is lymphatic spread</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: page 686, Williams Gynecology, 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 123408,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 19330,
    "choices": [
      {
        "id": 77280,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Allis tissue holding forcep</span></span></p>"
      },
      {
        "id": 77281,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Babcock forceps</span></span></p>"
      },
      {
        "id": 77282,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Cervical punch biopsy forcep</span></span></p>"
      },
      {
        "id": 77283,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Pipelle&rsquo;s endometrial biopsy forcep</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:#1a1a1a\">Identify the instrument: </span></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901124.jpg\" style=\"height:346px; width:200px\" /></p>",
    "unique_key": "Q4366747",
    "question_audio": null,
    "question_video": null,
    "map_id": 31092,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Cervical punch biopsy forceps</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li>This is a cervical punch biopsy forceps</li>\r\n\t<li>It is used to take a biopsy from a cervical growth or suspicious area on the cervix</li>\r\n\t<li>The biopsy is taken form the periphery of the cervical growth (Never from the center)</li>\r\n</ul>\r\n\r\n<p><strong>Other options:&nbsp;</strong></p>\r\n\r\n<ul>\r\n\t<li>Allis Foceps: It is used to hold tough structures&nbsp;</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>Babcock Forceps: It is an atraumatic forceps and is used to hold delicate structures like the fallopian tube</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>Endometrial aspiration cannula: It is a thin cannula which is introduced through the cervix to take an endometrial sample. It does&nbsp;</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Educational Objective:</strong></span></p>\r\n\r\n<ul>\r\n\t<li>Any growth on the cervix should be biopsied using a punch biopsy forceps</li>\r\n</ul>\r\n\r\n<p><strong>Ref: Page no 605, DC Dutta&#39;s Textbook of Gynecology, 6th edition</strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>",
    "correct_choice_id": 77282,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 19331,
    "choices": [
      {
        "id": 77284,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound </span></span></span></p>"
      },
      {
        "id": 77285,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT scan</span></span></span></p>"
      },
      {
        "id": 77286,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI</span></span></span></p>"
      },
      {
        "id": 77287,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imaging modalities should not be used for staging or management </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56 year old parous lady visits the gynecology OPD with complaint of vaginal bleeding. On examination, there is a 3 x 3cm&nbsp; growth involving cervix and upper part of vagina. Which of the following imaging would be most useful in staging and management of the disease?</span></span></span></p>",
    "unique_key": "Q1026961",
    "question_audio": null,
    "question_video": null,
    "map_id": 31093,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. MRI</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lymphangiography , CT, ultrasonography, magnetic resonance imaging (MRI), and positron emission tomography (PET) are used in an attempt to improve the accuracy of clinical staging</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A systematic review,&nbsp;&nbsp;comparing CT scan with MRI showed that MRI is significantly more sensitive with equivalent specificity. MRI has excellent sensitivity on T2 weighted images for detection of parametrial disease. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other Options</span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A: </span></span></span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">An Ultrasound idoes not procide any additional information to aid in staginig of cervical cancer</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong>Option B</strong>: CT scan: It is useful but an MRI is significantly more sensitive for detection of parametrial disease</li>\r\n\t<li style=\"text-align:justify\"><strong>Option D:</strong> As per FIGO 2018, the use of any of the imaging modalities according to available resources is permitted<strong>&nbsp;i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)</strong>, to provide additional information on tumor size, nodal status, and local or systemic spread.</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><strong>Educational Objective:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\">Cervical cancer is primarily a clinical staging but FIGO 2018 staging permits the use of any of the imaging modalities according to available resources,<strong> i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)</strong>, to provide additional information on tumor size, nodal status, and local or systemic spread.</span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref : </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Berek and novak 16<sup>th</sup> edition, 2457</span></strong></span></span></p>",
    "correct_choice_id": 77286,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19334,
    "choices": [
      {
        "id": 77296,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IA1 : microscopically detected carcinoma&nbsp; </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&le; 5</span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;mm depth and </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&le;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;7mm extension</span></span></span></p>"
      },
      {
        "id": 77297,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB1 : Cancer confined to cervix, lesion&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&le; 4</span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> cm in greatest dimension</span></span></span></p>"
      },
      {
        "id": 77298,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB2: Cancer confined to cervix, lesion &gt; 4 cm in greatest dimension</span></span></span></p>"
      },
      {
        "id": 77299,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IIA: Cervical carcinoma involving upper 2/3<sup>rd</sup> of vagina </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is TRUE regarding staging of cervical cancer?</span></span></p>",
    "unique_key": "Q9890925",
    "question_audio": null,
    "question_video": null,
    "map_id": 31094,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Stage IIA: Cervical carcinoma involving upper 2/3<sup>rd</sup> of vagina </span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Other Options can be ruled out by the staging of cervical cancer shown in the table below</em></span></span></strong></p>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage of cancer cervix (FIGO 2021)</span></span></span></strong></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901123.jpg\" /></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Educational Objective:</strong></span></p>\r\n\r\n<p>Staging of cervical cancer is primarily a clinical staging and it is important to know this staging as shown in the table above</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and novak 16<sup>th</sup> edition, 2455</span></strong></span></span></p>",
    "correct_choice_id": 77299,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19335,
    "choices": [
      {
        "id": 77300,
        "text": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Better disease eradication</span></span></span></span></p>"
      },
      {
        "id": 77301,
        "text": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Conservation of ovaries can be tried</span></span></span></span></p>"
      },
      {
        "id": 77302,
        "text": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Less bowel, bladder problems</span></span></span></span></p>"
      },
      {
        "id": 77303,
        "text": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Less sexual dysfunction</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Mrs Mala, a 40-year-old P2L2, underwent radical hysterectomy for cancer cervix.&nbsp; A<span style=\"color:black\">dvantages of surgery over radiotherapy in treatment of cervical cancer are all EXCEPT:</span></span></span></p>",
    "unique_key": "Q2822338",
    "question_audio": null,
    "question_video": null,
    "map_id": 31095,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A (better disease eradication)</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">The advantages of surgery over radiotherapy in treatment of cervical cancer are:</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\">Spread of the disease can be determined more thoroughly by surgicopathological staging.</li>\r\n\t<li style=\"text-align:justify\">Surgery can assess the&nbsp;paraaortic and pelvic nodes and can better predict the survival rate</li>\r\n\t<li style=\"text-align:justify\">Preservation of ovarian function, if desired, specially in a young woman</li>\r\n\t<li style=\"text-align:justify\">Ovaries may be transposed out of the radiation field if radiation is considered in the postoperative period</li>\r\n\t<li style=\"text-align:justify\">Retention of more functional and pliable vagina for sexual function</li>\r\n\t<li style=\"text-align:justify\">Psychologic benefit to the patient in that her cancer bearing organ has been removed</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901125.jpg\" style=\"height:531px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:67px\"><span style=\"font-size:14px\"><strong>Other Options:&nbsp;</strong></span></p>\r\n\r\n<ul>\r\n\t<li style=\"margin-right: 67px;\"><span style=\"font-size:14px\"><strong>Option B: C</strong>onservation of ovaries can be tried in surgical management in young patients wanting fertility sparing as they can be transpositioned out of the radiation field if post op RT is planned</span></li>\r\n\t<li style=\"margin-right: 67px;\"><span style=\"font-size:14px\"><strong>Option C:</strong> Less bowel bladder problems: Radiotherpay causes more bladder and bowel dysfunction as compared to surgery</span></li>\r\n\t<li style=\"margin-right: 67px;\"><span style=\"font-size:14px\"><strong>Option D: </strong>Less sexual dysfunction: Radiotherapy causes more sexual dysfunction as it causes vaginal fibrosis</span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:67px\"><span style=\"font-size:14px\"><strong>Educational Objective:&nbsp;</strong></span></p>\r\n\r\n<p style=\"margin-right:67px\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901125.jpg\" style=\"height:531px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Berek and novak, 16<sup>th</sup> edition 2470, 2487</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">DC Dutta&#39;s Textbook of Gynecology, 6th edition, page 348</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:67px\">&nbsp;</p>",
    "correct_choice_id": 77300,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 19336,
    "choices": [
      {
        "id": 77304,
        "text": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Type 1 hysterectomy</span></span></span></span></p>"
      },
      {
        "id": 77305,
        "text": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Type 2 hysterectomy</span></span></span></span></p>"
      },
      {
        "id": 77306,
        "text": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Type 3 hysterectomy</span></span></span></span></p>"
      },
      {
        "id": 77307,
        "text": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Type 4 hysterectomy</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mrs A, 56 year old woman, underwent <span style=\"color:black\">Wertheim&rsquo;s hysterectomy for cancer cervix. What type of hysterectomy is this :</span></span></span></p>",
    "unique_key": "Q6725721",
    "question_audio": null,
    "question_video": null,
    "map_id": 31096,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B. Type 2 hysterectomy&nbsp;</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li>&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The hysterectomy described by Wertheim is less extensive than a radical hysterectomy and removes the medial half of the cardinal and uterosacral ligaments.</span></span></span></span></li>\r\n\t<li><em><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This procedure is often referred to as modified radical or type II hysterectomy.</span></span></span></span></em></li>\r\n\t<li><em><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Wertheim&#39;s original operation did not include pelvic lymphadenectomy but instead included selective removal of enlarged lymph nodes. </span></span></span></span></em></li>\r\n\t<li><em><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The modified radical hysterectomy (type II) differs from the radical hysterectomy (type III - also called as Meig Hysterectomy) in the following ways:</span></span></span></span></em></li>\r\n</ul>\r\n\r\n<ol>\r\n\t<li><em><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\">The uterine artery is transected at the level of the ureter, thus preserving the ureteral branch to the ureter.</span></span></span></em></li>\r\n\t<li><em><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\">The cardinal ligament is not divided near the sidewall but instead is divided close to its midportion near the ureteral dissection.</span></span></span></em></li>\r\n\t<li><em><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\">The anterior vesicouterine ligament is divided, but the posterior vesicouterine ligament is conserved.</span></span></span></em></li>\r\n\t<li><em><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\">A smaller margin of vagina is removed</span></span></span></em></li>\r\n</ol>\r\n\r\n<p><strong><em><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\">Other Options:&nbsp;</span></span></span></em></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\"><strong>Option A</strong>: Type 1 hysterectomy<em> is also called an e</em>xtra-fasical hysterectomy <em>and is done in non malignant or pre-malignant conditions.</em>&nbsp;</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\">It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part</span></span></span></li>\r\n\t\t<li><span style=\"color:#000000; font-family:Calibri,sans-serif\"><span style=\"font-size:16px\">vaginal cuff is not removed</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:14px\"><strong>Option C:</strong> A Type 3&nbsp;hysterectomy is a</span><em>lso called as Meig Hysterectomy</em>\r\n\t<ul>\r\n\t\t<li><em>The cardinal ligament is&nbsp;divided near the sidewall (type 3)&nbsp;instead of&nbsp;close to its midportion near the ureteral dissection (type 2)</em></li>\r\n\t\t<li><em>UTerosacral ligaments divided at their origin near the sacrum</em></li>\r\n\t\t<li><em>A larger margin of vagina is removed in type 3 hysterectomy</em></li>\r\n\t\t<li><em>Complete dissection of the ureter</em></li>\r\n\t\t<li>Uterine artery divided at its origin</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:14px\"><strong>Option D:</strong> A type 4&nbsp;hysterectomy is an extended radical hysterectomy where more parametrial and vaginal tissue is removed</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Educational Objective:&nbsp;</strong></span></p>\r\n\r\n<p><span style=\"font-size:14px\">Types of hysterectomies:</span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\">A Type 1 hysterectomy<em> is also called an e</em>xtra-fasical hysterectomy <em>and is done in non malignant or pre-malignant conditions.</em>&nbsp;</span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\">It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part</span></li>\r\n\t\t<li><span style=\"font-size:14px\">No vaginal cuff is removed</span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:14px\">A Type 2 hysterectomy (Wertheim hysterectomy)</span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\">Uterine arteries divided just medial to the ureter</span></li>\r\n\t\t<li><span style=\"font-size:14px\">Uterosacral ligaments divided midway</span></li>\r\n\t\t<li><span style=\"font-size:14px\">Cardinal ligaments divided midway</span></li>\r\n\t\t<li><span style=\"font-size:14px\">2/3rd vaginal cuff is remove</span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:14px\"><em>Type 3- also called as Meig Hysterectomy</em></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><em>The cardinal ligament is&nbsp;divided near the sidewall (type 3)&nbsp;instead of&nbsp;close to its midportion near the ureteral dissection (type 2)</em></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><em>UTerosacral ligaments divided at their origin near the sacrum</em></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><em>A larger margin of vagina is removed in type 3 hysterectomy</em></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><em>Complete dissection of the ureter</em></span></li>\r\n\t\t<li><span style=\"font-size:14px\">Uterine artery divided at its origin</span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:14px\">A Type 4 hysterectomy is an extended radical hysterectomy where more parametrial and vaginal tissue is removed</span></li>\r\n\t<li><span style=\"font-size:14px\">A type 5 hysterectomy involves partial exenteration. Part of the bladder and distal ureteral segments are also removed.<em>&nbsp;</em>&nbsp;</span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:67px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref : Berek and Novak, 16<sup>th</sup> edition, page 2476</span></span></strong></span></span></p>",
    "correct_choice_id": 77305,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 19337,
    "choices": [
      {
        "id": 77308,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Uterus+ cervix + upper 1/3<sup>rd</sup> of vagina + pelvic lymph nodes + medial half of cardinal ligament</span></span></span></span></p>"
      },
      {
        "id": 77309,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Uterus + cervix + upper 2/3<sup>rd</sup> of vagina + pelvic lymph nodes + most of cardinal ligament</span></span></span></span></p>"
      },
      {
        "id": 77310,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Uterus + cervix + upper 2/3<sup>rd</sup> of vagina + pelvic lymph nodes + medial half of cardinal ligament</span></span></span></span></p>"
      },
      {
        "id": 77311,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Uterus + cervix + upper 1/3<sup>rd</sup> of vagina + pelvic lymph nodes + most of cardinal ligament</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Mrs Anita, a 70 year old woman has been counselled about radical hysterectomy and radiotherapy as treatment modalities for her cervcal cancer treatment. Meig&rsquo;s Radical hysterectomy or type III hysterectomy involves removal of:</span></span></span></p>",
    "unique_key": "Q9606691",
    "question_audio": null,
    "question_video": null,
    "map_id": 31097,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p style=\"margin-right:67px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: B:&nbsp;</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><em>Type 3&nbsp;- also called as Meig Hysterectomy</em>\r\n\r\n\t<ul>\r\n\t\t<li><em>The cardinal ligament is&nbsp;divided near the sidewall (type 3)&nbsp;instead of&nbsp;close to its midportion near the ureteral dissection (type 2)</em></li>\r\n\t\t<li><em>Uterosacral ligaments divided at their origin near the sacrum</em></li>\r\n\t\t<li><em>A larger margin of vagina is removed in type 3 hysterectomy (2/3rd)&nbsp;</em></li>\r\n\t\t<li><em>Complete dissection of the ureter</em></li>\r\n\t\t<li>Uterine artery divided at its origin</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>Other Options</p>\r\n\r\n<ul>\r\n\t<li><strong>Option A:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Uterus+ cervix + upper 1/3<sup>rd</sup> of vagina + pelvic lymph nodes + medial half of cardinal ligament: This does not describe any of the radical hysterectomy types</span></span></span></span></li>\r\n\t<li><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C:&nbsp;</span></span></span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Uterus + cervix + upper 2/3<sup>rd</sup> of vagina + pelvic lymph nodes + medial half of cardinal ligament: This describes a type 2 hysterectomy</span></span></span></span></li>\r\n\t<li><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:&nbsp;</span></span></span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Uterus + cervix + upper 1/3<sup>rd</sup> of vagina + pelvic lymph nodes + most of cardinal ligament:&nbsp;This does not describe any of the radical hysterectomy types</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Educational Objective:&nbsp;</strong></span></p>\r\n\r\n<p><strong>Types of hysterectomies:</strong></p>\r\n\r\n<ul>\r\n\t<li>A Type 1 hysterectomy<em> is also called an e</em>xtra-fasical hysterectomy <em>and is done in non malignant or pre-malignant conditions.</em>&nbsp;\r\n\r\n\t<ul>\r\n\t\t<li>It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part</li>\r\n\t\t<li>No vaginal cuff is removed</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>A Type 2 hysterectomy (Wertheim hysterectomy)\r\n\t<ul>\r\n\t\t<li>Uterine arteries divided just medial to the ureter</li>\r\n\t\t<li>Uterosacral ligaments divided midway</li>\r\n\t\t<li>Cardinal ligaments divided midway</li>\r\n\t\t<li>2/3rd vaginal cuff is remove</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><em>Type 3- also called as Meig Hysterectomy</em>\r\n\t<ul>\r\n\t\t<li><em>The cardinal ligament is&nbsp;divided near the sidewall (type 3)&nbsp;instead of&nbsp;close to its midportion near the ureteral dissection (type 2)</em></li>\r\n\t\t<li><em>Uterosacral ligaments divided at their origin near the sacrum</em></li>\r\n\t\t<li><em>A larger margin of vagina is removed in type 3 hysterectomy (2/3rd)</em></li>\r\n\t\t<li><em>Complete dissection of the ureter</em></li>\r\n\t\t<li>Uterine artery divided at its origin</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>A Type 4 hysterectomy is an extended radical hysterectomy where more parametrial and vaginal tissue is removed</li>\r\n\t<li>A type 5 hysterectomy involves partial exenteration. Part of the bladder and distal ureteral segments are also removed</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Ref : berek and novak, 16<sup>th</sup> edition, page 2476</strong></p>",
    "correct_choice_id": 77309,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased"
    ]
  },
  {
    "id": 19338,
    "choices": [
      {
        "id": 77312,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic hysterectomy with preservation of ovaries </span></span></span></p>"
      },
      {
        "id": 77313,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic hysterectomy with transposition of ovaries</span></span></span></p>"
      },
      {
        "id": 77314,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radical trachelectomy </span></span></span></p>"
      },
      {
        "id": 77315,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple trachelectomy</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mrs Rina, a 35 year old P1L1 has 1.5 x 1.5cm growth limited to the cervix. A biopsy reveals squamous cell carcinomal of the cervix and an MRI reveals no other involvement of surrounding structures. She wishes to undergo fertility preserving surgery and future childbearing . Which of the following would be an appropriate management for her: </span></span></p>",
    "unique_key": "Q4857793",
    "question_audio": null,
    "question_video": null,
    "map_id": 31098,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. C. Radical trachelectomy. </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Radical trachelectomy is a procedure that is gaining popularity as a surgical management option for women with stage 1A2 and IB1 disease who desire uterine preservation and fertility. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">As this patient would fall into Stage 1 A2, this treatment modality can be offered</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is Suitable for tumors less than 2cm size.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In radical trachelectomy, the following is removed</span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The cervix</span></span></span></span></li>\r\n\t\t<li>Part of parametria and paracolpos</li>\r\n\t\t<li>Part of uterosacral ligaments</li>\r\n\t\t<li>1-2 cm of vaginal cuff</li>\r\n\t\t<li>Descending cervico-vaginal branch of uterine artery is ligated</li>\r\n\t\t<li>Permamant encerclage of the cervical stump&nbsp;</li>\r\n\t\t<li>Pelvic lymoh nodes</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>Other Options:&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><strong>Option A:&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic hysterectomy with preservation of ovaries:&nbsp;</span></span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">This can also be considered in a woman wanting to preserve fertility but she will require a gestational surrogate</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option B:</strong>&nbsp;Laparoscopic hysterectomy with transposition of ovaries: Transposition of the ovaris is usually done if the woman is to recieve pelvic radiotherapy</span></span></span></li>\r\n\t<li><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple trachelectomy is not an option in early stage cervical cancer.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educatiional Objective:&nbsp;</span></span></strong></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Radical trachelectomy is a procedure that is gaining popularity as a surgical management option for women with stage 1A2 and IB1 disease who desire uterine preservation and fertility.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: berek and novak, 16<sup>th</sup> edition page 2473</span></span></strong></span></span></p>",
    "correct_choice_id": 77314,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 19341,
    "choices": [
      {
        "id": 77324,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB3</span></span></span></p>"
      },
      {
        "id": 77325,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IIA1</span></span></span></p>"
      },
      {
        "id": 77326,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IIA2</span></span></span></p>"
      },
      {
        "id": 77327,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IIB&nbsp;</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following stage of cancer cervix would best be managed surgically?</span></span></span></p>",
    "unique_key": "Q6634232",
    "question_audio": null,
    "question_video": null,
    "map_id": 31099,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:14px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Stage IIA1</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early stage cervical cancers less than 4 cm can be surgically managed </span></span></span></li>\r\n\t<li><span style=\"font-size:14px\">Surgical management is preferred for Stages 1 - 2A</span></li>\r\n\t<li><span style=\"font-size:14px\">However, in large tumor sizes, radiation may be preferable</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Other Options: </strong>Staging and Treatment of cervical cancer is shown in the table below</span></p>\r\n\r\n<table cellspacing=\"0\" class=\"MsoTableGrid\" style=\"border-collapse:collapse; border:none\">\r\n\t<tbody>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:126px\">\r\n\t\t\t<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Stage</strong></span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:210px\">\r\n\t\t\t<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Disease</strong></span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:288px\">\r\n\t\t\t<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Treatment</strong></span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td rowspan=\"2\" style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; height:36px; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">1A1</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; height:36px; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&lt; 3mm (- LVSI)</span></span></p>\r\n\r\n\t\t\t<p>&nbsp;</p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; height:36px; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Conization or extra-fascial hysterectomy</span></span></p>\r\n\r\n\t\t\t<p>&nbsp;</p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; height:36px; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&lt; 3mm (+ LVSI)</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; height:36px; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Modified radical trachelectomy or modified radical hysterectomy + pelvic lymphadenectomy</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">1A2</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&ge; 3mm &lt; 5mm</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Modified radical trachelectomy or modified radical hysterectomy + pelvic lymphadenectomy</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">1B1</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&ge; 5mm &lt; 2mm</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Modified radical/ radical trachelectomy or modified radical/ radical hysterectomy with pelvic lymphadenectomy</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">1B2</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&ge; 2cm &lt; 4cm</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Radical hysterectomy with pelvic lymphadenectomy</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">1B3</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&gt;4cm</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">2A1</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&lt; 4 cm + involvement of upper vagina</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Radical hysterectomy with pelvic lymphadenectomy OR Chemoradiation</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">2A2</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&ge; 4cm + involvement of upper vagina</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">2B</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + involvement of parametria (not till vaginal wall)</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">3A</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + lower vagina</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">3B</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + pelvic wall OR hydronephrosis</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic &plusmn; extended field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">3C1</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + pelvic lymph nodes</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic &plusmn; extended field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">3C2</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + para-aortic lymph nodes</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic &plusmn; extended field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">4A</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + Adjacent pelvic organs</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic &plusmn; extended field) OR exenteration</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">4B</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + Distant mets</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Systemic chemotherapy &plusmn; radiation </span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t</tbody>\r\n</table>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Educational Objective:&nbsp;</strong></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Staging and Treatment of cervical cancer is shown in the table below</strong></span></p>\r\n\r\n<table cellspacing=\"0\" class=\"MsoTableGrid\" style=\"border-collapse:collapse; border:none\">\r\n\t<tbody>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:126px\">\r\n\t\t\t<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Stage</strong></span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:210px\">\r\n\t\t\t<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Disease</strong></span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:288px\">\r\n\t\t\t<p style=\"text-align:center\"><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Treatment</strong></span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td rowspan=\"2\" style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; height:36px; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">1A1</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; height:36px; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&lt; 3mm (- LVSI)</span></span></p>\r\n\r\n\t\t\t<p>&nbsp;</p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; height:36px; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Conization or extra-fascial hysterectomy</span></span></p>\r\n\r\n\t\t\t<p>&nbsp;</p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; height:36px; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&lt; 3mm (+ LVSI)</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; height:36px; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Modified radical trachelectomy or modified radical hysterectomy + pelvic lymphadenectomy</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">1A2</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&ge; 3mm &lt; 5mm</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Modified radical trachelectomy or modified radical hysterectomy + pelvic lymphadenectomy</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">1B1</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&ge; 5mm &lt; 2mm</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Modified radical/ radical trachelectomy or modified radical/ radical hysterectomy with pelvic lymphadenectomy</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">1B2</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&ge; 2cm &lt; 4cm</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Radical hysterectomy with pelvic lymphadenectomy</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">1B3</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&gt;4cm</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">2A1</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&lt; 4 cm + involvement of upper vagina</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Radical hysterectomy with pelvic lymphadenectomy OR Chemoradiation</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">2A2</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">&ge; 4cm + involvement of upper vagina</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">2B</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + involvement of parametria (not till vaginal wall)</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">3A</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + lower vagina</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">3B</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + pelvic wall OR hydronephrosis</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic &plusmn; extended field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">3C1</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + pelvic lymph nodes</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic &plusmn; extended field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">3C2</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + para-aortic lymph nodes</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic &plusmn; extended field)</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">4A</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + Adjacent pelvic organs</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Chemoradiation (pelvic &plusmn; extended field) OR exenteration</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t\t<tr>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:126px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">4B</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:210px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Cervix + Distant mets</span></span></p>\r\n\t\t\t</td>\r\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:288px\">\r\n\t\t\t<p><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\">Systemic chemotherapy &plusmn; radiation</span></span></p>\r\n\t\t\t</td>\r\n\t\t</tr>\r\n\t</tbody>\r\n</table>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and Novak&rsquo;s 16<sup>th</sup> edition, page 2471, 2472</span></strong></span></span></p>",
    "correct_choice_id": 77325,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 30874,
    "choices": [
      {
        "id": 123374,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early age at first sexual intercourse</span></span></p>"
      },
      {
        "id": 123375,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></span></p>"
      },
      {
        "id": 123376,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone replacement therapy</span></span></p>"
      },
      {
        "id": 123377,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Family h/o breast cancer</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old woman presents to her gynecologist for her routine checkup. She reports no significant medical history and has been in good health. Her last pap smear was 5 years earlier and was normal. Her pelvic examination reveals a slightly enlarged cervix with a raised, friable lesion which bleeds on touch. A biopsy is performed, and histopathology confirms the presence of squamous cell carcinoma. Which of the following risk factors is most strongly associated with the development of cervical squamous cell carcinoma?</span></span></p>",
    "unique_key": "Q2120205",
    "question_audio": null,
    "question_video": null,
    "map_id": 31100,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Early age at first sexual intercourse </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk Factors for cervical cancer</span></strong></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">HPV (most important and also cause of cervical cancer)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Early age at 1<sup>st</sup> intercourse</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sexually transmitted diseases</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Early age at marriage</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple births</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Low socio-economic status</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">HIV +ve</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple sexual partners</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Smoking</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Uncertain relation with Combined OCPs</span></span></li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Infection with HPV is the most important risk factor and also cause of cervical cancer</span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 338, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 123374,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 30875,
    "choices": [
      {
        "id": 123378,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV 6 </span></span></p>"
      },
      {
        "id": 123379,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV 16</span></span></p>"
      },
      {
        "id": 123380,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV 18 </span></span></p>"
      },
      {
        "id": 123381,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV 31</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which human papillomavirus (HPV) subtype is most commonly associated with adenocarcinoma of the cervix? </span></span></span></p>",
    "unique_key": "Q3313072",
    "question_audio": null,
    "question_video": null,
    "map_id": 31101,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans: C. HPV 18</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">HPV is the primary etiologic infectious agent associated with cervical cancer</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#212121\">High-risk HPV types include types 16, 18, 31, 33, 34, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, and 70</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Majority of cervical cancers are attributed to HPV 16 and 18</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">HPV 16 is more commonly associated with squamous cell carcinoma of the cervix</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">HPV 18 is a risk actor or cervical adenocarcinoma </span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Majority of cervical cancers are attributed to high risk HPV types 16 and 18</span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 684, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 123380,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 30876,
    "choices": [
      {
        "id": 123382,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lugol solution </span></span></p>"
      },
      {
        "id": 123383,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emergent radiation</span></span></p>"
      },
      {
        "id": 123384,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine artery embolization </span></span></p>"
      },
      {
        "id": 123385,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monsel (ferric subsulfate) solution</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 54y woman presents to the OPD with post-menopausal bleeding. On a speculum examination, there is a fungating 4x3 cm growth seen arising from the cervix. A biopsy is taken but the patient starts profusely bleeding. Which of the following is not used for hemostasis in cases of life-threatening hemorrhage from suspected cervical cancer? </span></span></span></p>",
    "unique_key": "Q1893792",
    "question_audio": null,
    "question_video": null,
    "map_id": 31102,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans: A.</span> </strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lugol solution</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cervical cancer typically bleeds on touch and sometimes can present with heavy bleeding or during an examination, torrential bleeding can start from the tumor bed</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In such cases, bleeding can often be controlled with </span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaginal packing</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Combination of Monsel paste (ferric subsulfate) </span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Topical acetone can also be used to obtain hemostasis, especially in cases refractory to Monsel paste </span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">If bleeding continues, emergent radiation can be delivered.</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Uterine artery or Internal iliac artery embolization or ligation can be performed in cases of refractory hemorrhage</span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lugol&rsquo;s iodine is not going to stop the bleeding. It is used as a test for cervical cancer screening</span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cervical cancer typically bleeds on touch and sometimes can present with heavy bleeding or during an examination, torrential bleeding can start from the tumor bed</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In such cases, bleeding can often be controlled with </span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaginal packing</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Combination of Monsel paste (ferric subsulfate) </span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Topical acetone can also be used to obtain hemostasis, especially in cases refractory to Monsel paste </span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">If bleeding continues, emergent radiation can be delivered.</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Uterine artery or Internal iliac artery embolization or ligation can be performed in cases of refractory hemorrhage</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 662, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 123382,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 30877,
    "choices": [
      {
        "id": 123386,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform a pap smear </span></span></span></p>"
      },
      {
        "id": 123387,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform a cervical biopsy </span></span></span></p>"
      },
      {
        "id": 123388,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Refer to a gynecologic oncologist </span></span></span></p>"
      },
      {
        "id": 123389,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obtain a computed tomography (CT) scan</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman comes in for an annual gynecologic examination. During speculum examination, you see the following. What is the most appropriate next step?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/picture118_GSGLEOW.jpg\" style=\"height:274px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q9661827",
    "question_audio": null,
    "question_video": null,
    "map_id": 31103,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans: B. Perform a cervical biopsy.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">When a lesion is seen on the cervix, a biopsy should always be taken using a punch biopsy forceps</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In this image, a lesion is seen, so a biopsy should be taken from the periphery of the lesion</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A pap smear is done when there is no visible lesion on the cervix</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Imaging studies and referral to a gyn oncologist have a role in cervical cancer once a diagnosis is made</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">When a lesion is seen on the cervix, a biopsy should always be taken using a punch biopsy forceps</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In this image, a lesion is seen, so a biopsy should be taken from the periphery of the lesion</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 663, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 123387,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 30878,
    "choices": [
      {
        "id": 123390,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IB2</span></span></p>"
      },
      {
        "id": 123391,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IIB</span></span></p>"
      },
      {
        "id": 123392,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IIIB</span></span></p>"
      },
      {
        "id": 123393,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IVB</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman has a 6-cm adenocarcinoma of the cervix, positive para-aortic nodes found on positron emission tomography (PET) scan, and hydronephrosis. Based on these findings, which FIGO stage is she assigned? </span></span></span></p>",
    "unique_key": "Q8181260",
    "question_audio": null,
    "question_video": null,
    "map_id": 31104,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. IIIB</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is stage 3B due to the finding of hydronephrosis</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FIGO Staging of cervical cancer (2021)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/picture23_ZC18iSO.jpg\" style=\"height:1600px; width:904px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cervical cancer staging is a clinical staging which is aided by imaging and pathology.</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and Novak 16<sup>th</sup> edition, 2455</span></strong></span></span></span></p>",
    "correct_choice_id": 123392,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 30879,
    "choices": [
      {
        "id": 123394,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A </span></span></span></p>"
      },
      {
        "id": 123395,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></span></p>"
      },
      {
        "id": 123396,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C </span></span></span></p>"
      },
      {
        "id": 123397,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anywhere</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following arrows depicts where the uterosacral ligament is ligated during a type II radical hysterectomy?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/whatsapp-image-2023-12-18-at-174605.jpeg\" style=\"height:322px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q8925363",
    "question_audio": null,
    "question_video": null,
    "map_id": 31105,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans: B. B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Types of Hysterectomy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/screenshot-2023-12-18-180615.jpg\" style=\"height:715px; width:960px\" /></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this image, they have shown the utero-sacral ligaments and have asked about a type 2 hysterectomy; hence midway is the best answer</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a type 2 radical hysterectomy, the uterine vessels are ligated at the level of the ureter and the uterosacral ligaments are divided midway between the uterus and the sacrum</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a type 3 hysterectomy, the uterine vessels are ligated at the origin of the internal iliac vessels and the uterosacral ligaments are ligated near the sacrum</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 171, Williams Gynecology, 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 123395,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 30880,
    "choices": [
      {
        "id": 123398,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 cm lateral and 2 cm superior to the external os </span></span></span></p>"
      },
      {
        "id": 123399,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5 cm lateral and 2 cm superior to the external os </span></span></span></p>"
      },
      {
        "id": 123400,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 cm lateral and 5 cm superior to the external os </span></span></span></p>"
      },
      {
        "id": 123401,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5 cm lateral and 2 cm superior to the internal os</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In brachytherapy for cervical cancer, how is point A defined? </span></span></span></p>",
    "unique_key": "Q5748064",
    "question_audio": null,
    "question_video": null,
    "map_id": 31090,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans: A.</span></strong> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 cm lateral and 2 cm superior to the external os</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radiotherapy in cervical cancer</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Both external beam pelvic radiation and brachytherapy are typically delivered </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Of these, external beam radiation is usually given before intracavitary radiation (brachytherapy)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">External beam radiation is commonly administered in 25 fractions during 5 weeks (40 to 50 Gy). </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">During brachytherapy, bowel and bladder are packed away from the intracavitary source using vaginal packing during tandem insertion to limit radiation to these organs. </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Treatment is prescribed to </span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Point A</strong>: A point 2 cm lateral and 2 cm superior to the external cervical os; this point corresponds to the crossing of the uterine artery and ureter</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Point B:</strong> which is a point 3 cm lateral to point A; this point corresponds to the lateral pelvic wall/ obturator lymph nodes</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/whatsapp-image-2023-12-18-at-180614.jpeg\" style=\"height:465px; width:400px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cervical cancer, radiotherapy (brachytherapy) is prescribed to 2 points </span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Treatment is prescribed to </span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Point A:</strong> A point 2 cm lateral and 2 cm superior to the external cervical os; this point corresponds to the crossing of the uterine artery and ureter</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Point B:</strong>&nbsp;which is a point 3 cm lateral to point A; this point corresponds to the lateral pelvic wall/ obturator lymph nodes</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: page 672, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 123398,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 30881,
    "choices": [
      {
        "id": 123402,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radiation alone </span></span></span></p>"
      },
      {
        "id": 123403,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy </span></span></span></p>"
      },
      {
        "id": 123404,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total pelvic exenteration</span></span></span></p>"
      },
      {
        "id": 123405,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radiation with concomitant chemotherapy</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If a patient with stage IB1 squamous cell carcinoma recurs at the vagina after a radical hysterectomy with pelvic lymph node dissection, what is the most appropriate treatment?</span></span></p>",
    "unique_key": "Q8820008",
    "question_audio": null,
    "question_video": null,
    "map_id": 31091,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans: D.</span></strong> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radiation with concomitant chemotherapy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given scenario is of a recurrence</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">R</span></strong>isk factors for recurrent disease are: </span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Large tumor size</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lymph vascular space invasion</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Positive lymph nodes</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Advanced stage disease</span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Most common site of recurrence is the pelvic side wall. </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Features of disease recurrence are: Pain in the pelvis, back, unilateral leg edema, ureteral obstruction, vaginal bleeding, palpable tumor in the pelvis and lymphadenopathy. </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Treatment of recurrence: </span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Single agent or multiagent chemotherapy with cisplatin, paclitaxel or ifosfamide is used along with Radiation therapy may be used to those who have been treated initially with surgery. </span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Treatment of recurrence of cervical cancer: </span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Single agent or multiagent chemotherapy with cisplatin, paclitaxel or ifosfamide is used along with Radiation therapy may be used to those who have been treated initially with surgery. </span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 354, DC Duttas Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 123405,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  }
];
        let quizName = 'Gynae Oncology';
        let hierarchy = ["Cerebellum", "qBank", "Obstetrics & Gynecology"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }
            
            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>